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Abstract 
Given their capacity to self-renew and differentiate efficiently into the different cell 
types, Embryonic Stem Cells (ESCs) provide a valid model to understand the 
complex network of signaling interactions in the mammalian embryo and open up 
new possibilities for cell therapy. So a deeper understanding of the molecular 
mechanisms that regulate generation, self-renewal and differentiation of ESCs is 
become crucial not only to fulfill their clinical promise but also to get insight into the 
molecular mechanisms controlling early events of mammalian development. The 
emergence of microRNAs (microRNAs) as potent regulators of gene expression at 
the post-transcriptional level has broad implications in all facets of biology, 
including ESCs and early development.  
In recent years, the role of microRNAs in ESCs and mammalian embryogenesis 
has begun to be explored but specific roles of the microRNAs in the regulation of 
ESC specific fate are still largely unknown. In this context, our interest is to identify 
microRNAs regulating ESC functions. We performed a systematic comparison of 
microRNA expression in undifferentiated versus differentiating mouse ESCs. We 
report that different microRNAs are increased upon the induction of differentiation. 
We compared the entire list of candidate mRNA targets of upregulated microRNAs 
with that of mRNA dowregulated in ESCs upon the induction of differentiation. 
Among the candidate targets emerged from this analysis, we found three genes 
Smarca5, Jarid1b and Sirt1, previously demonstrated to be necessary to sustain 
the undifferentiated phenotype in ESCs. On this basis, we first demonstrated that 
Smarca5 is a direct target of miR-100, Jarid1b of miR-137 and confirmed 
previously published data demonstrating that Sirt1 is a direct target of miR-34a in 
a different context. The suppression of these three microRNAs by anti-miRs 
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caused block of ESC differentiation induced by LIF withdrawal. On the other hand, 
the overexpression of the three microRNAs resulted in an altered expression of 
differentiation markers. These results demonstrated that miR-100, miR-137 and 
miR-34a are required for proper differentiation of ESCs, and that they function by 
targeting, among the others, the mRNAs of Smarca5, Jarid1b and Sirt1. 
In conclusion, we have characterized a subset of microRNAs that are necessary 
for proper differentiation of mouse ESCs. The identification of microRNAs that are 
up-regulated upon the induction of ESC differentiation suggests that they 
suppress, directly or indirectly, the expression of genes necessary to maintain 
ESCs in the undifferentiated state. The identification of targets of the microRNAs 
that we have studied may provide tools to drive ESC differentiation towards 
specific lineages.  
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Introduction 
The discovery of mouse ESCs represented a major advance in biology and 
experimental medicine because it provided the basis for establishing an in vitro 
model of early mammalian development and represented a potential source of 
differentiated cell types for cell replacement therapy. However the application of 
ESC as a model for developmental biology has been limited and their use in cell 
replacement therapy remains a main goal in the field. So advances in our 
understanding of ESC differentiation are necessary to provide new insights 
essential for establishing ESC-based developmental models and for the 
generation of clinically relevant population for cell therapy.  
Mouse ESCs were first derived from the inner cell mass (ICM) of blastocyst-stage 
embryos in 1981 (Evans and Kaufman 1981). Blastocyst is a vesicular structure 
comprising of a cluster of cells, the inner cell mass (ICM), adhering to one side of 
the vesicle and of an epithelial outer layer, the trophectoderm (TE), enclosing a 
fluid filled space (the blastocoel cavity). The ICM is composed of approximately 20 
cells that give rise to all cells of the embryo, while TE cells give rise to 
extraembryonic tissues, such as placenta, critical for supporting embryonic 
development (Figure 1) (Ohtsuka and Dalton 2008). 
These two morphologically distinct cell types in the blastocyst express different 
sets of genes, which owing to their specificity and their changes in expression 
level drive the events of embryogenesis. 
Cdx2 and Eomes are two TE specifically genes, essential for the delineation of the 
cell lineage earlier in the compacting pre-implantation embryo (Strumpf, Mao et al. 
2005) and for proper differentiation of the TE into trophoblast (Russ, Wattler et al. 
2000). At the same time Oct3/4, Sox2, Nanog, Bmp4 and Nodal are the genes 
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specifically expressed in the ICM (Nichols, Zevnik et al. 1998; Niwa, Miyazaki et al. 
2000; Avilion, Nicolis et al. 2003; Chambers, Colby et al. 2003; Mitsui, Tokuzawa 
et al. 2003). Concurrent with the implantation of the blastocyst, the ICM gives rise 
to a new epithelial layer, the primitive endoderm (PrEn), on its blastocoelic 
surface. Later this epithelium also lines the luminal surface of the mural 
trophectoderm away from the ICM and contributes to the endoderm of the visceral 
and parietal yolk sac (visceral and parietal endoderm: VE and PE). In addition to 
the PrEn, the ICM gives rise to the epiblast of the post-implantation embryo from 
which all tissues of the embryo are derived (Rossant, Chazaud et al. 2003). 
Because some genes, such as Gata6, are expressed in the inner cell mass of the 
pre-implantation blastocyst and later shift their expression to the PrEn after this 
tissue is formed, it is postulated that the PrEn is formed by sorting of ICM cells that 
are committed to the PrEn lineage and by organizing them into an epithelial layer. 
So cells with divergent lineage fates may be present before the PrEn emerges 
(Pfister, Steiner et al. 2007). After the embryo has implanted in the uterus, the 
trophectoderm overlying the ICM (the polar TE) proliferates (Rossant and Cross 
2001) and grows into a thick column of extraembryonic ectoderm (ExE), which 
extends into the blastocoel and carries a compact epiblast at its distal pole. Both 
the ExE and the epiblast are enveloped by the VE. The embryonic epiblast is 
composed of a single layer of pseudostratified epithelia called primitive ectoderm, 
which give rise to all three embryonic germ layers (ectoderm, mesoderm and 
definitive endoderm) and primordial germ cells (Pfister, Steiner et al. 2007).  
All these steps of embryogenesis can be recapitulate by ESCs. In fact the 
importance of ESCs to modern biology and medicine derives from two unique 
characteristics that distinguish them from all other organ-specific stem cells 
identified so far. First, they can self-renew continuously if they are cultured under 
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conditions that prevent their differentiation, so they can be maintained and 
expanded as pure populations of undifferentiated cells for extended periods of 
time, possibly indefinitely, in culture. Second, they possess the remarkable 
property of pluripotency. 
 
Figure 1. Overview of peri-implantation mouse development. 
(1) Morula: around embryonic day 2.5. (2) Early blastocyst has two distinct cell types: ICM cells 
(blue) that gives rise to all cells of the embryo and TE cells (orange) which give rise to 
extraembryonic tissues. (3) At the late blastocyst stage of development the ICM is surrounded by a 
third cell type known as primitive endoderm (PrEn, green), that give rise to the yolk sac to support 
embryonic development. Formation of PrEn around the ICM denotes the epiblast stage of 
development. (4) Egg cylinder stage: PrEn differentiated toward visceral (VE) and parietal 
endoderm (PE) while a cavity forms resulting in the formation of a single layer of pseudostratified 
epithelia known as primitive ectoderm (PrEct). The cells of primitive ectoderm give rise to all three 
embryonic germ layers (ectoderm, mesoderm and definitive endoderm) and primordial germ cells. 
Adapted by (Ohtsuka and Dalton 2008).  
 
Pluripotency is a property of the ICM from which ESCs are derived, so they have 
the ability to differentiate into various cell types of a vertebrate embryo. In fact 
under appropriate conditions and after removal of factors that maintain ESCs in 
undifferentiated state, they can generate progeny consisting of derivatives of the 
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three embryonic germ layers: ectoderm, endoderm and mesoderm (Figure 2), 
(Keller 1995). 
  
Figure 2. Differentiation of ESCs. 
ESCs are able to differentiate into the derivatives of the three embryonic germ layers: ectoderm, 
endoderm and mesoderm. 
 
The most extraordinary characteristic of ESCs is that, even after extended 
propagation and manipulation in vitro, they hold the ability to re-enter 
embryogenesis. Indeed when introduced into the pre-implantation mouse embryo 
they colonize all fetal lineages plus yolk sac mesoderm, allantois and amnion and 
produce functional differentiated progeny in all tissues and organs. ESCs are able 
to colonize also the germ cell lineage, generating functional gametes because they 
maintain a diploid karyotype necessary for meoisis (Bradley, Evans et al. 1984). 
Traditionally, ESC pluripotency has often been defined as the ability to generate all 
cell types of an embryo apart from the trophectoderm. This is because an earlier 
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analysis of chimeric mouse embryos, produced by the injection ESCs into 
blastocysts, had shown that these cells are excluded from the trophectoderm 
lineage (Beddington and Robertson 1989). However, it has subsequently been 
found that the ICM and ESCs do still possess the ability to differentiate into the 
trophectoderm lineage (Pierce, Arechaga et al. 1988; Niwa, Toyooka et al. 2005). 
The ability for multilineage differentiation of ESC is reproduced in culture where 
these cells can produce a wide range of well-defined cell types. 
Three general approaches are used to initiate ESC differentiation. With the first 
method, ESCs are allowed to aggregate and form three-dimensional colonies 
known as embryoid bodies (EBs) (Doetschman, Eistetter et al. 1985; Keller 1995). 
This technique leads to formation of multidifferentiated structures in which the 
developmental program of ICM/epiblast cells is reactivated in the ESCs. Cellular 
differentiation proceeds on a schedule similar to that in the embryo but in the 
absence of proper axial organization or elaboration of a body plan (Doetschman, 
Eistetter et al. 1985). Each embryoid body develops multiple cell types, and further 
differentiation is elaborated on subsequent attachment and outgrowth. It is 
possible to bias the differentiation for or against specific cell types by addition of 
inductors, such as retinoic acid (Rohwedel, Guan et al. 1999). However, the final 
cultures are invariably a heterogeneous mixture (Keller 2005).  
With the second method, ESCs are cultured directly on stromal cells, and 
differentiation takes place in contact with these cells (Nakano, Kodama et al. 
1994). Another possibility is that ESCs are cultured in a medium, conditioned by 
other cell types. OP9 are the most commonly used stromal cell line for 
differentiation studies (Nakano, Kodama et al. 1994). They were originally isolated 
from CSF-1-deficient op/op mice (Yoshida, Hayashi et al. 1990). Coculture with 
stromal cells provides the beneficial growth promoting effects of the particular cell 
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line used. However, undefined factors produced by these supportive cells may 
influence the differentiation of the ESCs to undesired cell types. An additional 
problem with this method is the difficulty that can be encountered when attempting 
to separate the ESC-derived cells from the stromal cells (Keller 2005). 
The third protocol involves differentiating ESCs in a monolayer on extracellular 
matrix proteins (Nishikawa, Nishikawa et al. 1998). Differentiation in monolayers 
on known substrates can minimize the influence of neighboring cells and 
supportive stromal cells and in this regard is one of the simplest protocols. With 
this protocol the matrix proteins are critical, and different proteins may dramatically 
influence the generation and survival of the developing cell types (Keller 2005).  
 
 
 
Figure 3. Three different protocols used for ESC differentiation. 
Taken from Keller 2005. 
 
It seems that there is no intrinsic limitation to the ability of ESCs to differentiate in 
vitro. But can cells generated in vitro really acquire the full specialization of 
differentiated cell types in vivo? Remarkably, the available data indicate that ESC 
derivatives can become specialized to a high degree in culture. ESC progeny in 
fact, can express appropriate markers and functional attributes of specific cell sub-
types, such as neurons or cardiomyocytes, (Maltsev, Rohwedel et al. 1993; 
Strubing, Ahnert-Hilger et al. 1995; Lee, Hart et al. 2004). Accumulating evidence 
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from transplantation studies indicates that the specification of at least some ESC 
derivatives is sufficient to allow their integration into adult tissue. 
The opportunity to observe and then to manipulate such complex differentiation 
processes opens unheralded opportunities for mammalian developmental biology 
and cell engineering (Figure 4). 
 
 
 
 
Figure 4: Stem cell therapy. 
Outline of the isolation of human pluripotent stem cells, expansion in culture, differentiation into the 
cell type of relevance and transplantation. Stem cells may be derived from surplus preimplantation 
embryos generated in the course of in vitro fertilization treatment and donated for research, or 
possibly in future from embryonic entities produced by nuclear transfer. The second route would 
avoid any requirement for immunosuppression after transplantation (Smith 2001). 
 
Cell transplantation to restore tissue function after disease or injury is in theory 
applicable to a huge variety of human ailments, spanning neurodegeneration 
(Svendsen and Smith 1999), diabetes (Soria, Roche et al. 2000), and myocardial 
infarction (Klug, Soonpaa et al. 1996). 
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Recent studies with mouse ESCs offer encouragement in this regard, provided 
that mouse cells are a valid model for human pluripotent stem cells (hPSCs). Thus 
ESC-derived neural cells have been demonstrated to survive and to exhibit at 
least some aspects of appropriate region-specific neuronal differentiation when 
introduced into the developing mouse brain (Brustle, Spiro et al. 1997). In adults, 
transplantation of glial derivatives of ESCs results in a degree of remyelination in a 
rat model of multiple sclerosis (Brustle, Jones et al. 1999) and, most dramatically, 
to a partial functional recovery in a spinal cord injury model (Liu, Qu et al. 2000).  
In conclusion the possibility of propagating pluripotent stem cells from mammalian 
embryos is a gift from nature that has provided unparalleled research tools for 
investigating mammalian development, genetics and physiology. Now these cells 
offer the foundations for an entirely new form of human medicine. 
Therefore, a detailed understanding of the mechanisms that enable propagation of 
ESCs in a pluripotent state, such as signaling trasduction pathways, transcription 
factors, cell-cycle and epigenetic regulators, is essential to realize their therapeutic 
potential.  
Signaling trasduction pathways  
ESC pluripotency is maintained during self-renewal by the prevention of 
differentiation and the promotion of proliferation. For mouse ESCs, leukemia 
inhibitory factor (LIF), a member of the IL-6 cytokine family, is a key factor that 
prevents differentiation (Smith, Heath et al. 1988). After withdrawal of LIF from 
ESC culture medium, proliferation continues but differentiation is induced, and 
stem cells do not persist beyond a few days (Figure 5). LIF stimulates ESCs 
through the gp130, which works as a heterodimer together with LIF-Receptor.  
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Figure 5: ESC self-renewal and differentiation.  
Upper panel: diagram of alternative fates of an ESC and the effect of LIF. Lower panel: 
photographs of self-renewing ESC cultured in the presence of LIF (left) and differentiated 
derivatives 4 days after LIF withdrawal (right) (Smith 2001). 
 
Activation of gp130 leads to the activation of the Janus-associated tyrosine kinase 
(JAK) and of signal transducer and activation of transcription (STAT), (Figure 6). 
The ability of LIF to maintain the ESC self-renewal is dependent upon activation of 
STAT3 (Niwa, Burdon et al. 1998), whose activation is sufficient to prevent ESCs 
differentiation in the presence of serum (Matsuda, Nakamura et al. 1999). A 
downstream candidate target of activated STAT3 is c-Myc (Wang, Xie et al. 1998).  
In addition to STAT3 activation, LIF also stimulates the activation of the mitogen-
activated protein kinase (MAPK), which promotes differentiation (Burdon, Stracey 
et al. 1999). So ESCs can maintain their property in the presence of LIF due to the 
balance of the STAT3 activation and MAPK effect.A synergistic effect with LIF-
 16 
STAT3 pathways is given by Wnt pathway (Hao, Li et al. 2006). In fact Wnt 
signaling activation can upregulate STAT3 expression and elevate the level of c-
Myc. Wnt signaling is endogenously activated in ESCs and is downregulated upon 
differentiation (Sato, Meijer et al. 2004).  
Another important pathway for proliferation, survival and maintenance of 
pluripotency in ESCs is the Phosphoinositide 3-kinase (PI3K)/Akt pathway (Figure 
6). Two modulators of PI3K/Akt pathway are specifically expressed in ESCs, ERas 
and Tcl1 (Takahashi, Murakami et al. 2005). ERas encodes a constitutively active 
form of a Ras-family small GTPase that activates PI3K to stimulate ESC 
proliferation and tumorigenicity after ectopic transplantation in vivo (Takahashi, 
Mitsui et al. 2003). The Tcl1 gene product augments Akt activation by forming a 
stable heterodimeric complex with Akt (Teitell 2005).  
Also the members of TGF superfamily, including TGF!, Activin, Nodal and Bone 
morphogenic proteins (BMPs) are involved in ESC self-renewal and differentiation 
(Figure 6). In particular it has been demonstrated that LIF-STAT3 cannot maintain 
mouse ESCs in serum-free medium, indicating that there are many unknown 
factors present in serum, which are required to co-affect with LIF-STAT3. This 
serum factor is likely to be BMP4 acting via activation of Smad1/5/8. Addition of 
BMP4 to the media enables LIF to maintain mouse ESCs in serum-free culture 
(Ying, Nichols et al. 2003). Smad1/5 activation results in the expression of inhibitor 
of differentiation (Id) protein, which functionally antagonizes neurogenic bHLH 
transcription factors and blocks the neural differentiation (Gerrard, Rodgers et al. 
2005). Exogenous expression of Id mimics the effect of BMP4 in mouse ESCs 
(Ying, Nichols et al. 2003). Furthermore, BMP4 can maintain mouse ESCs in the 
presence of LIF, possibly by blocking the MAPK signaling cascade (Qi, Li et al. 
2004). 
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Figure 6. Key signaling pathways required for maintaining pluripotency of 
ESCs. 
LIF signaling activates JAK-STAT3 to induce target genes essential for pluripotency, such as c-
myc. C-myc is also regulated negatively by glycogen synthase kinase-3 (GSK3)! via inhibitory 
phosphorylation. LIF also induces MAP kinase activation, which antagonizes self-renewal and 
promotes differentiation. BMP signals potentially function in two ways: (i) activation of Smad1/5/8-
Id gene and (ii) suppression of p38 MAP kinase. Activin A has been shown to contribute to ESC 
proliferation but not to pluripotency. (Taken from Ohtsuka 2008 and modified). 
     
 
Transcription Factors 
In order to maintain the stable self-renewal of ESCs, the mechanisms that prevent 
their differentiation and promote their proliferation must be transmitted to their 
daughter cells. Thus, the expression levels of the genes that are involved in these 
mechanisms need to be stably maintained. 
A transcription factor network that is stabilized by positive and negative regulation 
between its components is a good mechanism for maintaining the stable gene 
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expression patterns that determine a particular cell phenotype (von Dassow, Meir 
et al. 2000). 
Oct3/4, Nanog and Sox2 transcription factors are essential for ESC self-renewal 
and differentiation. Some of these factors are expressed specifically in pluripotent 
cells, such as Oct3/4 and Nanog, and are switched ON/OFF by input 
environmental signals. They are also regulated by themselves. When these genes 
are expressed, the self-renewal genes are activated, and the differentiated genes 
are repressed. So ESCs can maintain their pluripotency. 
Oct3/4 
Oct3/4 (encoded by Pou5f1 gene) is a POU domain-containing transcription factor 
that binds to an octamer sequence, ATGCAAAT. Oct3/4 acts as gatekeeper to 
prevent ESC differentiation. In fact Oct3/4 is highly expressed in ESCs, and its 
expression decreases when these cells differentiate and lose pluripotency. The 
precise levels of this gene are required to maintain the ESC state. Loss of Oct3/4 
causes inappropriate differentiation of ESCs into trophectoderm. 
Oct3/4 has been reported to directly prevent differentiation towards trophectoderm 
by interacting with Cdx2 (a trigger for trophectoderm differentiation), to form a 
repressor complex. This complex interferes with the autoregulation of these two 
factors, giving rise to a reciprocal inhibition system that establishes their mutually 
exclusive expression (Niwa, Toyooka et al. 2005).  
LIF does not appear to regulate Oct3/4, and Oct3/4 does not appear to regulate 
Jak-STAT signaling, suggesting that the Oct3/4 pathway is a parallel pathway for 
maintaining ESC self-renewal. Many of Oct3/4 target genes also contain STAT-
binding sites, suggesting that the two transcription factors may cooperate in ESCs. 
In contrast with its target genes (Fgf4, Utf1, Opn, Rex1/Zfp42, Fbx15, and Sox2 
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(Nishimoto, Fukushima et al. 1999; Tomioka, Nishimoto et al. 2002; Zeng, Miura et 
al. 2004), little is known about upstream regulators.  
Nanog 
Nanog is a homeobox-containing transcription factor with an essential role in 
maintaining the pluripotent cells of the ICM and ESCs. It is expressed in 
pluripotent cells, and is absent in differentiated cells. Nanog disruption in ESCs 
results in differentiation to primitive endoderm (Liu, Lu et al. 2007).  
The mechanism through which Nanog regulates stem cell pluripotency remains 
entirely unknown. Based on the differences in gene expression between wild-type 
and Nanog null cells, it has been proposed that Nanog regulates pluripotency 
mainly as a transcription repressor for downstream genes that are important for 
cell differentiation such as Gata4 and Gata6 (Chambers, Colby et al. 2003; Mitsui, 
Tokuzawa et al. 2003). However, Nanog can also activate the genes necessary for 
self-renewal such as Rex1 and Oct3/4 (Pan, Li et al. 2006). Furthermore, Nanog 
promoter has been suggested as a direct target of the Oct3/4/Sox2 complex 
through ChIP analysis, in vitro-binding experiments and RNAi-mediated 
knockdowns (Boyer, Lee et al. 2005; Kuroda, Tada et al. 2005; Rodda, Chew et al. 
2005). 
The gatekeeper function of Nanog might not be restricted to preventing the 
differentiation of ESCs into primitive endoderm, as it has been reported that Nanog 
also blocks neuronal differentiation induced by the removal of LIF and BMPs from 
serum-free culture (Ying, Nichols et al. 2003). In addition, Nanog can also reverse 
mesoderm specification by repressing brachyury, which encodes the mesoderm-
specific T-box transcription factor T. This factor directly activates Nanog 
expression, indicating that negative feedback is involved in the balance between 
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self-renewal and mesodermal differentiation (Suzuki, Raya et al. 2006). Thus, 
Nanog can block primitive endodermal differentiation, neuronal differentiation and 
mesodermal differentiation under different culture conditions. 
Sox2 
Sox2 (SRY-related HMG box2), a member of the HMG-domain DNA-binding 
protein family, transcription factor occupies an important position in the 
maintenance of the pluripotent transcription factor network. Sox2 is known to co-
operate with Oct3/4 in activating Oct3/4 target genes (Yuan, Corbi et al. 1995). To 
date, ES-specific enhancers that contain binding sites for Oct3/4 and Sox2 have 
been identified in several genes, including Nanog (Boyer, Lee et al. 2005; Kuroda, 
Tada et al. 2005; Rodda, Chew et al. 2005) and Rex1, that is also directly 
regulated by Nanog (Shi, Wang et al. 2006). Interestingly, both Oct3/4 and Sox2 
possess enhancers that are activated by the Oct3/4-Sox2 complex in a stem-cell-
specific manner (Tomioka, Nishimoto et al. 2002; Chew, Loh et al. 2005; 
Okumura-Nakanishi, Saito et al. 2005). Knockdown of Sox2 in mouse ESCs 
induces differentiation into multiple lineages, including trophectoderm, indicating 
its functional importance in the maintenance of pluripotency (Ivanova, Dobrin et al. 
2006).  
Thus Oct3/4, Sox2, and Nanog may be the main transcriptional factors in 
regulating ESC pluripotency. Recent studies have enabled the construction of 
transcriptional regulatory networks in ESCs that provide a foundation for 
understanding how these factors control pluripotency and influence subsequent 
differentiation events. These key transcription factors have also been identified 
that form an intrinsic core-regulatory circuit that maintains ESCs in the pluripotent 
state in vitro (Figure 7).  
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Figure 7. A trascription factor network to control ESC self-renewal and 
differentiation. 
Transcription factor networks for pluripotent ESCs (green) and trophectoderm (yellow). Positive-
feedback loops between Oct3/4, Sox2 and Nanog maintain their expression to promote continuous 
ESC self-renewal. Cdx2 is autoregulated and forms a reciprocal inhibitory loop with Oct3/4, which 
acts to establish their mutually exclusive expression patterns. A combination of positive-feedback 
loops and reciprocal inhibitory loops converts continuous input parameters into a bimodal 
probability distribution, resulting in a clear segregation of these cell lineages (Adapted by Niwa 
2007). 
 
Cell-cycle regulators  
In contrast to somatic cells, ESCs have an abbreviated cell cycle. In fact, these 
cells divide very rapidly and transit the cell cycle once every 8-12 h, depending on 
the cell line and cultivation conditions. This feature, which may contributes to the 
self-renewal ability of these cells, depends on a very short G1 phase (only 1-2 h) 
(Stead, White et al. 2002; Becker, Ghule et al. 2006).  
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Somatic cells require mitogen activated cyclin dependent kinases (CDK) 4 and 6, 
cyclins (D and E) and members of the retinoblastoma (Rb) tumor suppressor 
protein family to transit from G1 into the S phase. Instead in ESCs a constitutively 
active CDK2-cyclin E activity drives cell division. Moreover, ESCs express very 
low levels of D-type cyclins, whose levels increase dramatically during in vitro and 
in vivo differentiation (Liu, Lu et al. 2007) and possess inactive forms of members 
of the retinoblastoma (Rb) tumor suppressor protein family. The only cell cycle 
regulators that show cell cycle-dependent expression in ESCs are CDK1 and 
cyclin B1, both of which show regulation during the G2 phase of the cell cycle 
(Stead, White et al. 2002).  
After DNA damage, somatic cells undergo cell-cycle arrest in the G1 phase to get 
rid of the damaged DNA, while ESCs choose apoptosis or differentiation instead of 
going through the checkpoint between the G1 phase and S phase. Indeed the 
mechanisms involved in G1/S checkpoint in somatic cells cycle 
(chk1/chk2/Cdc25A and p53-p21) are not functional in ESCs (Aladjem, Spike et al. 
1998; Bartek and Lukas 2001; Asahi, Otsu et al. 2004; Hong and Stambrook 
2004).  
Recent studies demonstrated that p53 plays an important role in ESC response to 
low levels of DNA damage that are normally introduced in rapidly dividing cells. It 
was proposed that p53 coordinate ESC self-renewal capability and DNA damage 
responses by directly suppressing Nanog expression and therefore inducing 
differentiation (Lin, Chao et al. 2005). So p53 is another mechanism for repressing 
Nanog expression when ESCs differentiate (Xu 2005).  
When relatively high levels of DNA damage have been introduced ESCs undergo 
apoptosis. In fact the function of p53 in ESCs may also be to trigger apoptosis to 
eliminate the cells with damaged DNA (Fluckiger, Marcy et al. 2006). So p53 may 
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activate apoptosis or differentiation pathways depending on stress type and 
severity. For example in response to endogenous reactive oxygen species (ROS), 
ESCs undergo mitochondrial-dependent apoptosis, triggered by p53 translocation 
to mitochondrial instead of to nucleus. In this context Sirt1, a p53 deacetylase, 
plays a fundamental role in p53 subcellular localization because blocks nuclear 
translocation of p53, thus inhibiting p53-mediated suppression of Nanog 
expression observed in Sirt1-/- ESCs (Han, Song et al. 2008). 
Epigenetic Modifications 
Differentiation of ESCs from pluripotent to developmentally more restricted states 
is accompanied by global changes in genome expression patterns. Genes active 
in earlier progenitors are gradually silenced at developmentally later stages, and 
subsets of cell type-specific genes are turned on. This progression is the result of 
selectivity active expression of transcription factors in concert with epigenetic 
modification. 
The idea that the epigenetic modifications contribute to determine pluripotency or 
differentiation of ESCs is supported by the evidence that the inactivation of 
components (Snf2b, Snf2h, Snf5, etc.) of the chromatin remodeling system affects 
the viability of F9 EC cells (Bultman, Gebuhr et al. 2000; Klochendler-Yeivin, Fiette 
et al. 2000; Stopka and Skoultchi 2003).  
Epigenetic modifications refer to meiotically and mitotically heritable changes in 
gene expression that are not coded in the DNA sequence itself (Levenson and 
Sweatt 2005). In mammals, epigenetic processes mainly include DNA methylation, 
histone modification and noncoding RNA-mediated processes. Epigenetic features 
in ESCs are different from the somatic cells: the pluripotent epigenome keeps the 
chromatin structure open to allow rapid genetic regulation (Figure 8).  
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Figure 8. Characteristics of pluripotent epigenome. 
Epigenetic features of the pluripotent cell nucleus. The volume of the nucleus is larger than that of 
a differentiated cell as a result of the relaxed chromatin structure. Small regions of perinuclear 
heterochromatin exist, but most of the chromatin exists as euchromatin, bearing histone marks 
associated with transcriptional activity. The hyperdynamics of chromatin proteins (green) might 
contribute to the maintenance of euchromatin. Bivalent domains are also a feature of the 
pluripotent epigenome, in which active histone marks (such as H3K4me) are flanked by 
transcriptionally repressive histone marks (such as H3K9me) (Niwa 2007). 
 
 
In fact, ESCs chromatin displays characteristics of loosely euchromatin, such as 
an abundance of acetylated histone modifications and increased accessibility to 
nucleases (Meshorer and Misteli 2006). 
ESCs undergo functionally important global and gene-specific remodeling of 
chromatin structure during in vitro differentiation. Increase in the heterochromatin 
marker 3methylated residue K9 of histone H3 (3meH3K9) and a decrease in the 
global levels of acetylated histones H3 and H4 (a euchromatin marker) were 
observed during RA-induced differentiation (Lee, Hart et al. 2004). Furthermore, 
histone deacetylase (HDACs) and methyl-CpG-binding protein (MECPs) are 
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expressed in ESCs and their levels are dynamically regulated as cells undergo 
differentiation (Rao 2004). 
DNA methylation 
DNA methylation is a covalent modification of cytosine at position C5 in CpG 
dinucleotides. In mammals, over 70% of CpG dinucleotides are methylated and 
nearly all DNA methylation occurs on CpG dinulceotides that are 
underrepresented in the genome with the exception of CpG islands (CpG 
clusters). Unmethylated CpG islands are usually found in the promoters and in the 
first exons (Jones and Takai 2001). DNA methylation is catalyzed by several DNA 
methyltransferase (DNMTs). The de novo establishment of DNA methylation relies 
on DNMT3a and 3b, whereas the maintenance of DNA methylation depends on 
DNMT1 that specifically recognizes semi-methylated DNA and methylates the 
remaining strand (Bestor 2000). DNMT2 does not have methyltransferase activity 
and its function is not clear (Okano, Xie et al. 1998). DNMT3L (DNMT3-like) lacks 
enzymatic activity, but could act as a cofactor for DNMT3a and 3b and modulate 
their enzymatic activity.  
Mammalian DNA methylation has been implicated in a wide range of cellular 
functions, including tissue-specific gene expression, cell differentiation, cell fate 
determination, genomic imprinting, and X chromosome inactivation (Bird 2002). 
DNA methylation is a fundamental process that ESCs use to silence genes 
required for induction of differentiation. This was demonstrated in experiments in 
which ESCs, deficient either in the DNA methyltransferases DNMT1, both 
DNMT3a and DNMT3b, or the CpG island-binding protein CGBP that binds to non-
methylated DNA, showed severe DNA hypomethylation and a complete 
differentiation block (Jackson, Krassowska et al. 2004; Carlone, Lee et al. 2005). 
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Moreover recent exciting discoveries showed that exogenous expression of 
Oct3/4, Sox2, c-Myc- and Klf4 could induce pluripotency in fibroblasts derived from 
either embryonic or adult mice or humans (Takahashi, Tanabe et al. 2007; Wernig, 
Meissner et al. 2007). These induced pluripotent stem cells (iPS) exhibit many in 
vitro properties as ESCs but a different in vivo pluripotency ability depending on 
their DNA methylation state. The iPS lines that have high level of DNA methylation 
pattern at Oct 3/4 promoter exhibit low germ line transmission efficiency, whereas 
the iPSs that exhibit low Oct3/4 promoter methylation similar to that of ESCs have 
high germ line incorporation efficiency (Okita, Ichisaka et al. 2007).  
Histone modifications 
Histone modifications encompass a range of modifications, including acetylation, 
methylation, phosphorylation, ADP ribosylation and ubiquitylation, that extend the 
information content of the underlying DNA sequence and confer unique 
transcriptional potential. Histone modifications can have both repressive and 
activating functions. The best-understood modifications are the trimethylation of 
the Lys9 and Lys27 residues of histone H3 (3meH3K9 and 3meH3K27), which 
have repressive functions, and 3meH3K4 and H3K9 acetylation (H3K9ac), which 
are associated with active genes.  
In addition, mono-, di-, and trimethylation at the same lysine residues lead to 
different levels of gene activation or repression and are involved in distinct cellular 
pathways.  
The initial histone modification studies were focused largely on histone acetylation 
that is catalyzed by two opposing enzymes, histone acetyltransferease (HAT) and 
histone deacetylase (HDAC). To date, at least 6 HATs and HAT complexes and 18 
HDACs have been identified in mammals (Lee and Workman 2007; Xu, Parmigiani 
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et al. 2007). Similarly, histone methylation and demethylation enzymes are also 
involved in cellular functions. One of the best studied histone methylation is the 
methylation of H3K9 by SUV39h, ESET and G9a. In ESCs, proper H3K9 
methylation is critical for regulated expression of imprinted genes (Mikkelsen, Ku 
et al. 2007). Recently, the discovery of histone demethylases has greatly 
advanced our understanding in chromatin-mediated gene regulation (Klose and 
Zhang 2007).  
A series of recent studies have reveled that ESCs possess certain novel 
epigenetic features consisting in a complex of proteins that act mainly to stabilize a 
repressive chromatin structure. These complex of proteins are Polycomb group 
(PcG) proteins required for early developmental gene expression (Pasini, Bracken 
et al. 2004). They can facilitate oligomerization, condensation of chromatin 
structure, and inhibition of chromatin remodeling activity. PcG proteins bind to a 
large set of genes composed of transcriptional regulators and signaling factors, 
which promote ESC differentiation. Many of the target genes were de-repressed in 
the absence of the PcG components. Thus, PcG proteins make an essential 
contribution to the ESC state by repressing the premature expression of 
differentiation genes. But when ESCs differentiate, these target genes were 
preferentially activated. That is to say PcG repress differentiation gene expression 
in a flexible manner, which can be reversed later by gene-specific and lineage-
specific signals (Bernstein, Mikkelsen et al. 2006; Boyer, Plath et al. 2006; 
Buszczak and Spradling 2006; Lee, Jenner et al. 2006). 
PcG proteins form three complexes: Polycomb repressive complex 2 (PRC2), 
PRC1, and PhoRC (Schuettengruber, Chourrout et al. 2007). PRC2 is involved in 
the initiation of silencing and contains histone deacetylase and histone H3K27 
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methyltransferase activities, and PRC1 is implicated in maintaining gene 
repression (Valk-Lingbeek, Bruggeman et al. 2004). 
microRNAs 
Transcription factors are essential players in regulating ESC functions but recently, 
post-transcriptional gene regulation is emerging as another essential regulator of 
ESC development (Cheng, Tavazoie et al. 2005). In particular it was demonstrated 
that a crucial role in the post-transcriptional regulation of gene expression is 
played by microRNAs (Bartel 2004).  
microRNAs are 20–25 nucleotide (nt) non-coding RNAs that bind to the 3' 
untranslated region (UTR) of target mRNAs through an imperfect match to repress 
their translation and stability (Rana 2007). This is achieved by forming a 
ribonucleoprotein complex, called the RNA-induced silencing complex (RISC), that 
contains an Argonaute family member. microRNAs are derived from precursor 
transcripts, called primary microRNAs (pri-microRNAs), that are first processed in 
the nucleus into an intermediate form (pre-microRNAs) by the Microprocessor 
protein complex; this contains the Drosha and DiGeorge syndrome critical region 
gene 8 (DGCR8; also known as Pasha) proteins. The pre-microRNAs are then 
translocated by the exportin5 exportin 5–RanGTP shuttle system into the 
cytoplasm, in which they are further processed by Dicer, an RNase III-like enzyme, 
into mature microRNAs (Figure 9), (Gangaraju and Lin 2009). microRNAs are also 
produced by two non-canonical, Drosha- or Dicer-dependent pathways. In the first 
pathway, the early processing step is done by spliceosome and by a debranching 
enzyme that yields a short hairpin that is ready for further processing by Dicer. 
These non-canonical microRNAs have been termed mirtrons (Okamura, Hagen et 
al. 2007; Ruby, Jan et al. 2007).  
 29 
 
 
 
 
Figure 9. Biogenesis and regulatory features of the microRNA patways. 
MicroRNA (microRNA) genes are transcribed by RNA polymerases II and III into primary 
transcripts called the pri-microRNAs. These are processed into pre-microRNAs in the nucleus by a 
Microprocessor complex, which contains the RNase III enzyme Drosha and the double-stranded 
RNA-binding protein DiGeorge syndrome critical region gene 8 (DGCR8; also known as Pasha). 
Some microRNAs, called mirtrons, have also been shown to be generated from introns that bypass 
Drosha requirement. Pre-microRNAs are then transported by exportin 5, which is a karyopherin, 
and RanGTP into the cytoplasm, where they are further processed by the RNAse III enzyme Dicer. 
This results in double-stranded 20–25 nucleotide (nt) intermediates with 2 nt overhangs on the 3' 
end. One of the RNA strands is then loaded by Dicer into an RNA-induced silencing complex 
(RISC), which contains an Argonaute-subfamily member, that then targets the 3' untranslated 
region of the target mRNAs by an imperfect match between the microRNA and the mRNA, to 
repress translation. However, it has been recently shown that microRNAs can activate translation 
of target mRNAs (Gangaraju and Lin 2009). 
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In the second pathway, short hairpin RNAs (shRNAs) are processed by unknown 
nucleases into pre-microRNAs and are further processed into microRNAs by 
Dicer. microRNAs that are derived in this way have been termed endogenous 
shRNA-derived microRNAs (Babiarz, Ruby et al. 2008). 
Recently, the ESCs and microRNA fields have converged with the identification of 
ESC specific microRNAs (Houbaviy, Murray et al. 2003). In addition to canonical 
microRNAs, mirtrons and shRNA-derived microRNAs have also been identified in 
ESCs (Babiarz, Ruby et al. 2008). It is now clear that microRNAs provide a new 
dimension to the regulation of ESC functions. Based on their function in 
translational attenuation, microRNAs seem to regulate ESC fate and behavior by 
fine-tuning the protein levels of various factors that are required for stem cell or 
niche cell functions.  
The overall function of the microRNA pathway in ESCs has been evaluated in 
humans and mice by analyzing the phenotypes of DGCR8 and Dicer mutants, 
respectively, as these two proteins have crucial roles in the production of mature 
microRNAs.  
DGCR8-deficient ESCs exhibit either delayed or reduced expression of 
differentiation markers, as well as delayed kinetics of cell cycle progression. Most 
DGCR8-deficient ESCs are arrested in the G1 phase, which indicates that the 
main function of the microRNA pathway is to promote the ESC cycle at the G1–S-
phase transition. In addition, DGCR8-null ESCs exhibit differentiation defects as 
they fail to stably silence the expression of self-renewal markers, such as Oct3/4, 
Rex1, Nanog and Sox2. In support of this, injected DGCR8-mutant ESCs into host 
mice fail to differentiate into different germ layers, in contrast with injected wild-
type ESCs that can give rise to teratomas, tumours that can give rise to cell types 
of all three germ layers (Wang, Medvid et al. 2007).  
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The crucial role of microRNAs in ESCs was also demonstrated by Berstein and 
co-workers, which reported that Dicer is essential for early mouse development, as 
its absence leads to embryonic lethality (Bernstein, Kim et al. 2003). In fact, in 
their study Berstein and co-workers demonstrated that after Dicer +/- mice 
intercrossing, of all mice born none were homozygous mutants, suggesting that 
the Dicer1-deficient mice are not viable. Moreover they did not obtain Dicer -/- 
embryos older than E7.5, suggesting that Dicer is essential in early stage of 
development. Another important evidence was that at E7.5, the number of Dicer1-
null embryos was 50% lower than expected from mendelian ratios, probably 
because a fraction of the embryos died at an even earlier stage of development. 
Finally they reported that Dicer1-deficient embryos had also defects in 
differentiation marker expression. Indeed they did not observe brachyury 
expression, suggesting that development of Dicer1 mutants is arrested before the 
body plan is configured during gastrulation.  
Whereas the Dicer and DGCR8 ESC mutants provide an overall assessment of 
the function of the microRNA pathway in ESCs, cloning and deep sequencing of 
microRNAs from ESCs have revealed the identity of the specific microRNAs that 
are expressed in ESCs and might function in self-renewal and differentiation of 
ESCs. For example, in mice, the cloning and sequencing of small RNAs revealed 
that the miR-290–295 cluster is specific to ESCs and that its levels decreases as 
ESCs differentiate. In a simplified way, this indicates that the miR-290–295 cluster 
has specific roles in maintaining pluripotency (Houbaviy, Murray et al. 2003). 
However, more recent studies indicate that the real role of miR-290–295 is to 
induce differentiation. Indeed this cluster achieves this role by stably targeting 
repressors of DNMTs, such as retinoblastoma like-2 (RBL2), which methylate CpG 
islands, leading to stable epigenetic repression of Oct3/4 transcription (Benetti, 
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Gonzalo et al. 2008; Sinkkonen, Hugenschmidt et al. 2008). However, it remains 
to be addressed whether and how this epigenetic repression of Oct3/4 
transcription is sufficient to promote differentiation, given that DNMTs are global 
regulators of CpG island methylation status in the entire genome.  
By contrast, levels of miR-21 and miR-22 increase substantially following the 
induction of differentiation, which indicates that these microRNAs might have 
important roles in stem cell differentiation. A recent study shows that miR-21  has 
potential binding sites in the 3' UTRs of the mRNAs that encode for Nanog, Sox2 
and possibly Oct3/4 and that the transcription of miR-21 is regulated in ESCs by a 
transcriptional repressor called the RE1-silencing transcription factor REST, which 
directly interacts with cis elements upstream of the miR-21 gene (Singh, 
Kagalwala et al. 2008).  
Other differentiation-related microRNAs, miR-134, miR-296 and miR-470, were 
recently found to target coding regions of Nanog, Sox2 and Oct3/4 to promote 
differentiation (Tay, Zhang et al. 2008).  
Although different studies have revealed the specific microRNAs that are 
expressed in ESCs only in few cases it was identify the function in self-renewal 
and differentiation of ESCs of the specific microRNAs. Indeed while it is becoming 
increasingly evident that microRNAs have crucial roles in the self-renewal and 
differentiation of ESCs, research on the role of microRNAs in ESCs is still in its 
infancy, in particular for what concerns the role of microRNAs in assisting ESC 
differentiation. In fact microRNAs exhibit a high degree of stage- and tissue-
specificity and the expression profile of microRNAs strictly depends on the 
differentiation program occurring. As consequence specific roles of the microRNAs 
in the control of ESCs specific fate are still largely unknown and have to be 
investigated. 
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Result 
microRNA expression profile  
In order to identified microRNAs assisting ESC differentiation and to characterize 
their functional role we analyzed changes in the expression levels of microRNAs 
as a consequence of ESC differentiation, by collecting RNA samples from mouse 
E14 cells grown in undifferentiated conditions and after 48 and 96 hours in 
differentiation conditions (See Methods and Figure 10).  
 
 
 
Figure 10. Profiling workflow. 
ESCs were grown in undifferentiated conditions and in differentiation culture medium for two and 
four days. Then RNA samples were collected from these cells and used for microRNA expression 
analysis. 
  
We chose to collect RNA samples at two early time points of the differentiation 
program because we were interested in the characterization of microRNAs 
controlling the first phases of differentiation decision.  
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The collected RNA samples were first validated and then used to measure the 
abundance of microRNAs by Taqman procedure. To confirm that at these two time 
points the cells have undergone a differentiation program we measured the 
abundance of stemness and differentiation markers by using real-time PCR 
procedure. As shown in figure 11, stemness markers, such as Oct4, Nanog and 
Rex1 decreased at 2 and 4 days of differentiation, while early differentiation 
markers, such as Fgf5 (Fibroblast growth factor 5, embryonic visceral endoderm 
marker) and Sox1 (neuroectodermal marker) appeared specifically upon 
differentiation induction. 
 
 
 
Figure 11. RNA sample validation. 
Stemness and early differentiation marker evaluation in undifferentiated (ESCs) and in 2 and 4 
days differentiating ESCs. 
 
To perform TaqMan microRNA profiling we used two pre-configured microfluidic 
cards, each containing 384 pairs of dried TaqMan primers and a probe for the 
detection of each microRNA annotated in the Sanger miRBase version 10 
database (Figure 12).  
This procedure provided specificity for the mature form of microRNAs, a highly 
specific quantization and also a single-base discrimination among very similar 
microRNAs. 
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Figure 12. microRNA quantization by using TaqMan Arrays. 
The TaqMan Array functions as an array of reaction vessels for the PCR step. Typically, the wells 
of the TaqMan Array contain dried TaqMan primers and probe for real-time amplification of user-
specified microRNAs. Relative levels of microRNA expression are determined from the 
fluorescence data generated during PCR.  1) Synthesis of cDNA from total RNA samples and 
loading into the fill reservoirs. 2) Centrifugation of cards to distribute the cDNA samples to the 
reaction wells. 3) TaqMan Array sealing. 4) Run on the 7900HT Applied Biosystem instrument. 
(Taken from Applied Biosystem). 
 
The results of TaqMan microRNA expression profile allowed us to cluster 
microRNAs in five groups. We reported: 78 microRNAs decreased upon the 
induction of ESC differentiation (Table1); 29 microRNAs undetectable in 
undifferentiated ESCs and expressed upon the induction of the differentiation 
program (Table 2); 162 microRNAs already expressed in ESCs and increased 
upon differentiation induction (Table 3, 4 and 5); 104 microRNAs undetectable 
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both in undifferentiated and differentiated ESCs (Table 6); 105 microRNAs 
unmodified upon the induction of differentiation (Table 7). 
The analysis of groups of microRNAs whose profiling was already described in 
ESCs allows us to validate our data. In fact, we verified if there was coherence 
between our microRNA expression data and published microRNA expression 
profiles. In particular, in the group of microRNAs decreased upon the induction of 
ESC differentiation we found microRNAs belonging to the miR-290 cluster, already 
known to be specific of the undifferentiated state of ESCs. We found that this 
cluster of microRNAs quickly decreased upon ESC differentiation. Opposite to this 
group, we found that microRNAs belonging to the miR-302 family are strongly 
induced upon the activation of the differentiation program, as reported in the 
literature (Figure 13). So we can conclude that there was a good degree of 
correlation between our data and literature data. 
 
 
   
 
Figure 13: Expression profile of microRNAs, belonging to miR-290 cluster 
and miR-302 family.  
The level of each microRNA, at day 2 and 4 of differentiation, is expressed as relative quantity of 
its level (set to 1) in undifferentiated ESCs. Because the expression levels of microRNAs, 
belonging to miR-290 cluster, were plotted as log10(RelativeQuantity), microRNA expression levels 
in undifferentiated ESCs appear as 0. All fold-expression changes were calculated using the 
equation 2
-"ct. 
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microRNA target prediction  
When ESCs are grown in undifferentiated conditions, stemness-related genes are 
activated while differentiation-related genes are repressed. When differentiation 
starts, stemness genes have to be repressed and differentiation genes activated. 
So we speculated that microRNAs induced after the induction of differentiation can 
work as integral component of the gene regulation circuitry and therefore can 
contribute to the down-regulation of stemness genes.  
So we focused on the up-regulated microRNAs upon ESC differentiation induction 
and performed for them the target prediction by using TargetScan database, 
version 5.1. To select candidate targets, we compared this list of predicted targets 
with available list of mRNAs down-regulated upon ESCs differentiation (Loh, Wu et 
al. 2006), because we considered that RNAs targeted by a microRNA are 
generally degradated (Liu, Bezprozvannaya et al. 2008; Viswanathan, Daley et al. 
2008). This approach allowed us to observe that many targets of up-regulated 
microRNAs are significantly downregulated in differentiating ESCs (Figure 14 and 
Table 8).  
In this list of candidate targets, we noted some mRNAs encoding proteins involved 
in chromatin remodeling, a crucial event in ESC differentiation. Among them, we 
selected three candidates whose functions are particularly relevant for ESC 
differentiation. They are Smarca5, putative target of miR-100, Jarid1b, candidate 
target of miR-137, and Sirt1, possible target of miR-204 and miR-217. Sirt1 was 
previously demonstrated to be target of the miR-34a (Han, Song et al. 2008), a 
microRNA presents in our list of up-regulated microRNAs (see Table 3) but that 
did not appear as targeting Sirt1 in TargetScan database version 5.1.  
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Figure 14. Strategy used to identify putative targets of the up-regulated 
microRNAs and list of genes down-regulated in differentiating ESCs and 
candidate targets of the up-regulated microRNAs. 
 
miR-100, miR-137, miR-204 and miR-217 belong to the group of microRNAs 
undetectable in undifferentiated ESCs and expressed upon the induction of the 
differentiation program (Figure 15), while miR-34a belongs to the group of 
microRNAs expressed in ESCs and increased upon the induction of differentiation 
(Table 3). For miR-100 and miR-137 we confirmed TaqMan expression profile by 
Northern blot Analysis (Figure 15). 
The three putative targets of the microRNAs that we have selected are considered 
key molecules in ESC functions. Smarca5, also known as Snf2h, is a member of 
the SWI/SNF family of proteins and a component of the chromatin remodeling and 
spacing factor RSF (Babiarz, Ruby et al. 2008). Smarca5 is required for survival of 
blastocyst-derived stem cells in vitro and its knockout results in early arrest of 
embryonic development, before implantation, suggesting that it is required for the 
proper development of the ICM (LeRoy, Loyola et al. 2000).  
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Figure 15. miR-100, miR-137, miR-204 and miR-217 expression profile in 
differentiating ESCs. 
Left panel: TaqMan microRNA expression profile in ESCs and differentiating ESC derivatives. 
Right panel: Northern blot analysis in ESCs and differentiating ESC derivatives. 0, 2 and 4 are 
days after differentiation. Gel was stained with Ethidium bromide for loading control. 
 
Similarly, Jarid1b, also known as KDM5b, is a histone H3K4 demethylase (Stopka 
and Skoultchi 2003) that is expressed in ESCs and in the very early steps of 
embryonic development. Its constitutive expression in ESCs prevents 
differentiation and sustains the expression of undifferentiated ESC markers 
(Seward, Cubberley et al. 2007). The third candidate target, SIRT1, a well known 
histone and p53 deacetylase, is required in ESCs to maintain high levels of 
responsiveness to endogenous reactive oxygen species.  In particular Sirt1 
regulates apoptosis and Nanog expression in ESCs by controlling p53 subcellular 
localization in response to reactive oxygen species (Babiarz, Ruby et al. 2008). 
Smarca5, Jarid1b and Sirt1 are targets of miR-100, miR-137 and miR-34a, 
respectively 
We confirmed by western blot analysis that the expression levels Sirt1, Smarca5 
and Jarid1b are significantly reduced upon the induction of ESC differentiation 
(Figure 16).  
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Figure 16. Sirt1, Jarid1b, and Smarca5 are decreased during ESC 
differentiation. 
Protein levels of Sirt1, Jarid1b, and Smarca5 were measured in undifferentiated (ESCs) and 2 and 
4 days differentiated ESCs. Significant decrease of protein levels was detected already at 2 days of 
differentiation. Right panel shows densitometric analysis of western blot. Relative quantity is 
calculated by assigning the arbitrary value 1 to the amount found in undifferentiated ESCs. Error 
bars represent SD of three separate experiments.  
 
Thus we addressed whether the overexpression of our selected microRNAs in 
undifferentiated ESCs was able to induce a decrease of their putative targets at 
protein level. As shown in figure 17, the protein levels of Smarca5, Jarid1b and 
Sirt1 are significantly decreased upon overexpression of miR-100, miR-137 and 
miR-34a, respectively, while overexpression of miR-204 and miR-217 had no 
effects on Sirt1 protein.  
Smarca5, Jarid1b and Sirt1 are direct targets of miR-100, miR-137 and 34a, 
respectively 
We addressed whether miR-100, miR-137 and 34a were able to bind directly 
Smarca5, Jarid1b and Sirt1 3’UTR, respectively.  
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Figure 17. miR-100, miR-137 and miR-34a target Smarca5, Jarid1b and Sirt1 
respectively. 
Smarca5, Jarid1b and Sirt1 are suppressed by microRNA overexpression. The decrease of 
Smarca5, Jarid1b and Sirt1 induced by miR-100, miR-137 and miR-34a, respectively was 
measured by densitometric analysis of western blot. Relative quantity is calculated by assigning 
the arbitrary value 1 to the amount found in cells transfected with control microRNA. Standard 
deviations refer to the valued obtained in three separate experiments. In all the cases the 
differences vs control microRNA transfected cells is significant with p< 0.001. 
 
To do this, we generated constructs encoding luciferase followed by the 3’UTR of 
the three target mRNAs or the corresponding antisense fragments.  
We expected that if miR-100, miR-137 and 34a were able to directly bind the 
corresponding 3’UTR on luciferase transcript, there should be a luciferase activity 
inhibition after microRNA overexpression (Figure18). 
After the transfection in 293 cells of all our three luciferase constructs, the 
Luciferase expression was affected by the overexpression of the corresponding 
microRNA, while in the all cases of Luc-antisense construct transfection the 
luciferase expression was unaffected (Figure 19).  
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Figure 18. Luciferase assay strategy. 
Luciferase constructs encoding the 3’UTR of Smarca5, Jarid1b and Sirt1 mRNAs or the 
corresponding antisense fragments were generated. We evaluated luciferase activity after miR-
100, miR-137 and 34a overexpression. 
 
 
 
 
Figure 19. Smarca5, Jarid1b and Sirt1 are direct target of miR-100, miR-137 
and miR-34a, respectively.  
Luciferase constructs bearing the 3’UTRs or inverted 3’UTRs of the three mRNAs were transfected 
in HEK293 cells together with the cognate microRNA or control microRNA. Luciferase assays 
demonstrated a significant (p<0,01) downwregulation due to microRNA co-transfection. Constructs 
bearing the antisense 3’UTRs were unaffected by the microRNA expression. The data were 
normalized with Renilla luciferase activity.  
 
We then explored whether physiologic increase of endogenous miR-100, miR-137 
or 34a was able to induce a downregulation of Luc expression, similar to that 
observed with the cognate overexpressed microRNAs. To this aim, we generated 
stable ESC clones by transfection with Luc constructs bearing the direct or reverse 
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3’ UTR of Smarca5, Jarid1b and Sirt1. The resulting ESC clones were induced to 
differentiate in order to activate the physiologic microRNA expression. In 
undifferentiated ESC clones, bearing the 3’ UTR of Smarca5 and Jarid1b, the 
Luciferase expression was robust and decreased upon the induction of 
differentiation (Figure 20), thus demonstrating that endogenous microRNAs 
accumulated in differentiating cells to levels sufficient to target the two 
corresponding 3’UTR and to downregulate the reporter. As a control, we 
demonstrated that the Luc constructs bearing the antisense UTRs were 
transcribed to the same extent before and after the induction of differentiation. 
 
 
 
Figure 20. Smarca5 and Jarid1b 3’UTR is targeted by endogenous 
microRNAs.  
ESCs stable clones for luciferase constructs bearing the 3’UTRs or inverted 3’UTRs of Smarca5 
and Jarid1b were induced to differentiate. Luciferase expression measured at 4 day of 
differentiation is strongly (p<0,01) decreased specifically in clones with the 3’UTRs. The data are 
normalized with total protein amount. 
 
The rate of luciferase inhibition in differentiating ESC clones, bearing the 3’ UTR 
Luc construct for miR-100 and miR-137, is higher than luciferese inhibition in 293 
cells, transiently transfected with the same luc constructs and overexpressing the 
cognate microRNAs. We reasoned that this difference in luciferase inhibition was 
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due to the difference in luciferase expression in transiently transfected 293 and 
stable clones. In fact the latter had a much more lower level of luciferase 
expression.  
The undifferentiated Luc-Sirt1 ESC clone showed very low levels of luciferase 
expression probably due to the presence of miR-34a also in undifferentiated 
conditions. In this case we could not test the effect of endogenous miR-34a on Luc 
construct.  
miR-100 and miR-137 overexpression affected Smarca5 and Jarid1b 
signaling pathways respectively 
We next analized for Smarca5, Jarid1b and Sirt1 signaling pathways to verify 
whether the overexpression of their cognate microRNAs affected their biological 
functions.  
Smarca5 is the SWI/SNF-related matrix-associated actin-dependent regulator of 
chromatin, subfamily a, member 5. Three known families of ATP-dependent 
chromatin remodeling complexes exist: the SWI/SNF-family, the ISWI family and 
the Mi-2 family, distinguished by their catalytic ATPase subunit. Smarca5 is the 
ATPase subunit of the major mammalian ISWI ATP-dependent chromatin 
remodeling complex. Smarca5 interacts with a variety of DNA-binding factors. In 
several instances these interactions have been shown to result in transcriptional 
repression. For example, the NORC complex, containing the ISWI ATPase 
Smarca5 and the nucleolar protein Tip5, has been shown to repress ribosomal 
gene transcription by recruiting DNA methyltransferase and histone deacetylase 
activities to rDNA promoters, to establish structural characteristics of 
heterochromatin such as DNA methylation, histone hypoacetylation and 
methylation on lysine 9 (Santoro, Li et al. 2002). 
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Moreover, by immunoprecipitation and GST pull-down experiments, it was 
demonstrated that Smarca5 interacts with the de novo DNA methyltransferase, 
DNMT3b, critical for embryonic development. DNMT3b also interacts with HDAC1, 
HDAC2, HP1 proteins and Suv39h1. All these proteins co-localize extensively with 
each other and with DNMT3b and Smarca5 in heterochromatic regions (Geiman, 
Sankpal et al. 2004). Suv39h1 is believed to be important mediator of histone H3 
methylation on lysine 9 (meH3K9) (Lehnertz, Ueda et al. 2003). This histone 
modification is recognized and bound by HP1 proteins (Eskeland, Eberharter et al. 
2007). 
There is clear evidence that DNA methylation, supported by DNMT3B interaction 
with Smarca5, is required to reinforce and maintain meH3K9 patterns (Fahrner, 
Eguchi et al. 2002; Nguyen, Weisenberger et al. 2002).  
Therefore, Smarca5 knockdown may be associated with modifications of 
chromatin methylation state, resulting in decreased meH3K9. 
Moreover it was previously demonstrated that the knockdown of Smarcc1, another 
member of the ATP-dependent chromatin remodeling complexes, significantly 
reduced 3meH3K9 in retinoic acid treated ESCs.  
All these previous observation supported our idea to verify that Smarca5 is 
required for changes in ESC chromatin structure and in particular for 3meH3K9. 
As expected Smarca5 knockdown decreased global 3meH3K9 (Figure 21). Then 
we tested if overexpression of miR-100 interfered with Smarca5 function in 
chromatin methylation changes. As shown in figure 21 miR-100 overexpression 
inhibited the 3meH3K9 at the same level of the shRNA specific for Smarca5.  
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Figure 21. miR-100 down-regulates Smarca5 and inhibits 3meH3K9. 
Protein levels of 3meH3K9 were measured in undifferentiated ESCs transfected with miR-100 or 
with a miR-Ctrl. We reported also 3meH3K9 protein level after transfection  with a specific shRNA 
targeting Smarca5 with its cognate control. Protein levels were normalized for histone H4 protein 
total amount. 
 
Jarid1b is a specific demethylase of lysine 4 of histone H3 (meH3K4). Dey and 
colleagues demonstrated that Jarid1b demethylates and thereby represses the 
promoters of different modulators of ESC fate decision, such as Egr1, p27 and 
BMI1 genes (Dey, Stalker et al. 2008). So we decided to assess whether miR-137 
overexpression was able to affect Egr1 repression, as consequence of Jarid1b 
suppression.  As shown in figure 22 after miR-137 overexpression the promoter of 
Egr1 gene showed a significant increase in 3meH3K4 levels with consequent 
increase in Egr1 transcript. So we concluded that miR-137 downregulated Jarid1b 
and interfered with the ability of this protein to repress Egr1 promoter.  
Yamakuchi and colleagues demonstrated that miR-34a overexpression in HCT116 
downregulated Sirt1, a class III histone deacetylases (HDACs), and consequently 
its signaling pathways. In fact they demonstrated that because Sirt1 can induce 
p53 deacetylation, miR-34a overexpression increased p53 acetylation as 
consequence of Sirt1 downregulation. Furthermore miR-34a overexpression 
increased expression of p21 and PUMA, both transcriptional targets of p53 
(Yamakuchi, Ferlito et al. 2008). 
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Figure 22. miR-137 overexpression affected Jarid1b signaling pathways.  
Left panel: qChip analysis of 3MeH3K4 in Egr1 promoter after Jarid1b downregulation, induced by 
miR-137 overexpression or by a trasfection of cells with an shRNA against Jarid 1B. Right panel: 
mRNA expression level of Egr1 gene after miR-137 overexpression. 
 
When we overexpressed miR-34a in ESCs we did not observe an increase in p53 
acetylation also after damage induction by exposition to UV radiation (Figure 23).  
 
Figure 23. miR-34a does not increase p53 acetylation in ESCs.  
ESCs transfected with miR-34a or with a control were exposed to 60 J/M
2 
UV radiation and 
harvested 16 hour after treatment. Sirt1 and acetylated p53 protein level were measured by 
western Blot analysis. Protein amount was normalized by measure of total p53 level. 
 
To explain our result we reasoned that ESCs probably possess a Sirt1-indipendent 
system to block p53 acetylation and therefore nuclear translocation of p53 after 
damage induction. This is because ESCs prefer the mitochondrial transcription-
independent killing action of p53 to nuclear transcription-dependent apoptosis, 
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since the first is more rapid (Erster, Mihara et al. 2004). In fact it was 
demonstrated that SIRT1 blocks nuclear translocation of p53 induced by oxidative 
stress via its deacetylation, while induces mitochondrial translocation and 
consequently the activation of the trascription-indipendent killing activity of p53. As 
consequence, in damaged ESCs, the suppression of Sirt1 by mir-34a 
overexpression is not sufficient to elevate the level of acetylated-p53, which is too 
dangerous for damaged ESCs that prefer to die via apoptosis instead of being 
repaired. 
Overexpression of miR-100, miR-137 and miR-34a is compatible with the 
persistence of the undifferentiated phenotype 
The important role of Smarca5, Jarid1b and Sirt1 in the maintenance of the ESC 
undifferentiated phenotype suggests the possibility that downregulation of these 
genes driven by miR-100, miR-137 and miR-34a in undifferentiated cells may have 
effects on the undifferentiated phenotype or even may induce ESC differentiation 
(Figure 24).  
 
 
Figure 24. Workflow of experiments based on microRNA overexpression.   
ESCs were transfected with microRNA mimics, grown in undifferentiating or differentiating 
conditions and then analyzed for stemness and differentiation marker expression. 
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Thus, to explore this possibility, ESCs grown in undifferentiated conditions were 
transfected with the single microRNA or with a mixture of the three microRNA 
mimics. 48 and 72 hours after transfection we analyzed the expression of 
stemness markers, such as Oct3/4 and Nanog mRNAs and alkaline phosphatase 
(AP), that resulted unmodified compared to that observed in cells transfected with 
control microRNA (Figure 25). 
Accordingly, no inappropriate differentiation was observed, and markers of 
differentiation such as Sox1 (ectoderm), Sox17 (endoderm) and Brachyury 
(mesoderm) were undetectable both in control and miR-transfected cells. 
 
 
Figure 25. miR-100, miR-137 and miR-34a overexpression does not affect 
ESC phenotype in undifferentiating conditions. 
Left panel: miR-100, miR-137 and miR-34a were transfected singly or as a mixture of three (MIX) 
in undifferentiated ESCs. Expression levels of stemness marker Oct3/4 and Nanog measured at 48 
and 72 hours after trasfection were unchanged upon single microRNA overexpression as well as 
upon overexpression of the three microRNAs (MIX) at the same time. mRNA expression levels 
were reported as relative fold changes compared to the data obtained in control microRNA 
transfected cells. Right panel: we measured the number of alkaline phosphatase positive colonies 
obtained from microRNAs mixture and control transfected cells, grown 5 days at low density. 
 
 
Another possibility that deserves to be examined is that the overexpression of 
these microRNAs in ESCs modifies the ability to proper differentiate. To address 
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this point, we transfected ESCs with the mixture of the three microRNA mimics, 
and then induced them to differentiate. As shown in figure 26, we did not observe 
any change in Oct3/4 and Nanog downregulation upon the induction of 
differentiation, thus indicating that overexpression of the microRNAs did not impair 
the ability of the cells to differentiate.  
 
 
 
Figure 26. miR-100, miR-137 and miR-34a overexpression does not affect the 
decrease of stemness markers during ESC differentiation.    
ESCs were transfected with a mixture of miR-100, miR-137 and miR-34a and induced to 
differentiate. Expression levels of stemness markers Oct3/4 and Nanog were measured at different 
time points (0, 3 and 6 day of differentiation). No differences were found in Oct3/4 and Nanog 
expression profile during differentiation in microRNA mixture (MIX) transfected cells compared to 
control microRNA transfected cells (Ctrl). The data were normalized to internal control. 
 
However, early differentiation markers, examined at various days after the 
induction of differentiation, showed some significant differences between cells 
transfected with control microRNA and the mixture of the three upregulated 
microRNAs (Figure 27). The most relevant difference was observed in the case of 
the mRNA of Sox1, an early marker of neural differentiation, which resulted 
significantly more expressed in microRNA-transfected cells than in control cells, at 
day 6 of differentiation. A similar increase was observed in the case of Sox17, 
marker of endoderm. These results suggest that the main functional role of the 
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three microRNAs is in the regulation of ESC differentiation and not in the 
maintenance of the undifferentiated phenotype. 
 
 
 
 
Figure 27. miR-100, miR-137 and miR-34a overexpression induces an early 
differentiation marker appearance in differentiating ESCs. 
Expression levels of differentiation markers were measured in microRNA mixture and control 
microRNA transfected cells during differentiation (0, 3, 6 and 9 days of differentiation). The 
expression level of Sox1 (ectoderm) and Sox17 (endoderm) appeared slightly increased in 
microRNA overexpressing cells (MIX) compared to control cells (Ctrl).  
 
Inhibition of miR-100, miR-137 and 34a results in the block of ESC 
differentiation 
We explored whether the knockdown of miR-100, miR-137 and miR-34a hampers 
ESC differentiation. ESCs were transfected with the single anti-miRs or with 
mixtures of them. The cells were grown in the absence of LIF for 5 days to 
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promote spontaneous differentiation into multiple lineage and then the stemness 
markers were analyzed (Figure 28).  
 
 
 
 
Figure 28. Schematic representation of anti-microRNA expression and 
consequent functional analysis.   
ESCs were transfected with anti-microRNAs, grown in the absence of LIF for 5 days and then 
analyzed for stemness marker expression. 
 
The suppression of single microRNAs had no effect on the expression of 
stemness markers Oct3/4, Nanog and Rex1, which decreased to the same extent 
in control and microRNA-transfected cells, when spontaneous differentiation 
occurred (data not shown). On the contrary, when the cells were transfected with 
the mixture of all three microRNAs, the expression of the stemness makers was 
maintained elevated even 5 days after LIF withdrawal (Figure 29). Accordingly, 
analysis of the expression of another marker of stemness, the alkaline 
phosphatase (AP), demonstrated that the cells transfected with the three 
microRNAs generated a significantly higher number of AP positive colonies than 
control microRNA transfected cells. 
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Figure 29. miR-100, miR-137 and miR-34a suppression induces maintenance 
of stemness marker expression in differentiating ESCs.   
ESCs were transfected with a mixture of anti-miR-100, anti-miR-137 and anti-miR-34a and the 
levels of stemness markers (Oct3/4, Nanog and Rex1) were measured after 5 days of culture in 
absence of LIF. Expression of stemness markers appears significantly higher in cells transfected 
with anti-miR mixture compared to the control.  
 
Furthermore, the shape of the colonies and the intensity of AP staining in 
microRNA-transfected cells were similar to that observed in the cells grown in 
undifferentiated conditions (Figure 30 and data not shown). In conclusion, 
suppression of miR-100, miR-137 and miR-34a clearly hampered ESC 
differentiation.  
In vivo analysis of anti-miR transfected ESCs 
When injected subcutaneously in nude mice, ESCs give rise to teratomas 
containing well-differentiated mesodermal, ectodermal, and endodermal tissue and 
cell types (Nishikawa, Jakt et al. 2007), (Figure 31). So we expected that ESCs, 
unable to correctly differentiate, could impair teratoma formation after injection in 
nude mice.  
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Figure 30. Effect of miR-100, miR-137 and miR-34a suppression impairs ESC 
differentiation. 
Number of alkaline phosphatase positive colonies was measured after 5 days of culture in absence 
of LIF in both anti-miR mixture and control miR transfected cells. Anti-miR mixture transfected cells 
showed maintenance of alkaline phosphatase expression with colonies wider and more stained 
than the control. Error bars represent SD of triplicates. 
 
 
 
 
 
Figure 31. ESCs give rise teratomas when implantated in nude mice. 
ESCs ability to give teratoma derived from their pluripotent state. The same cells can be injected 
into blastocyst to obtain chimeric mouse, in which ESCs are integrated into the embryo and give 
rise to all cell lineages (Nishikawa, Jakt et al. 2007). 
 
 
To investigate this point we transfected ESCs with an anti-miR-Ctrl or with a 
mixture of anti-miR-100, anti-miR-137 and anti-miR-34a. Then the cells were 
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grown in a culture medium without LIF and after 5 days implanted subcutaneously 
in nude mice. We injected anti-miR mixture and anti-miR control transfected cells 
on the left and on the right side of the same mice, respectively (n=3). In all three 
mice the anti-miR mixture transfected ESCs formed very small teratomas 
compared with teratomas formed by control cells, but without any evident 
histological difference (Figure 32). These results indicated that the suppression of 
miR-100, miR-137 and miR-34a blocks ESC differentiation capacity and therefore 
their ability to generate fully developed teratoma. The formation of a small tumor 
by anti-miR transfected ESCs could be due to few cells that did not incorporate the 
anti-miR mixture during transfection. 
 
 
 
     
 
 
Figure 32. Teratoma formation in nude mice.  
The suppression of miR-100, miR-137 and miR-34a blocks ESC differentiation capacity, reducing 
their teratoma formation ability. Left panel: Nude mouse injected with ESCs transfected with an 
anti-miR-Ctrl (right side) and with anti-miR-MIX (left side). Central panel: Examples of teratomas 
formed after injection in nude mice of ESCs transfected with anti-miR-Ctrl (upper tumor) and anti-
miR-MIX (lower tumor). Right panel: Haematoxylin-eosin staining of teratomas formed by ESCs 
transfected with anti-miR-Ctrl (upper sections) and anti-miR-MIX (lower sections).  
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microRNA 
2 days 
(fold 
change) 
4 days  
(fold 
change) 
Ct ESCs Ct ESCs Ct 2d Ct 2d Ct 4d Ct 4d 
let-7a* 0,976 0,401 35,984 35,982 36,143 35,989 35,222 35,975 
miR-10a* 0,950 N.D. 35,980 34,991 35,801 35,982 40,000 40,000 
miR-127* 1,199 0,129 33,564 34,981 34,599 34,180 33,797 35,993 
miR-141 1,263 0,198 30,976 30,984 30,955 30,971 32,974 32,982 
miR-141* 0,516 N.D. 32,471 31,043 31,974 33,994 40,000 40,000 
miR-142-3p 2,337 0,237 29,980 29,974 28,960 28,957 31,988 31,973 
miR-142-5p 3,521 0,423 34,966 34,982 33,973 32,964 34,976 35,918 
miR-150 0,343 0,052 25,978 25,964 27,977 27,967 29,958 29,969 
miR-154* 1,102 0,235 30,920 30,771 30,585 30,967 32,305 31,869 
miR-182 1,840 0,359 23,954 24,989 23,947 23,959 25,993 25,971 
miR-183 1,583 0,349 28,981 28,996 27,989 27,997 29,977 29,965 
miR-183* 1,147 0,161 26,986 27,926 27,894 27,795 28,809 28,858 
miR-196a* 0,961 0,251 35,099 34,954 34,984 34,975 35,919 34,307 
miR-200a 0,800 0,281 26,946 27,969 27,955 27,951 28,951 28,965 
miR-200a* 0,437 0,102 31,811 31,235 32,888 32,220 33,987 33,461 
miR-200b 0,872 0,267 25,990 25,978 26,990 26,989 27,978 27,973 
miR-200b* 0,269 0,085 32,445 32,917 34,215 33,223 36,042 33,408 
miR-200c 0,807 0,157 25,981 25,972 26,973 26,958 27,960 27,971 
miR-200c* N.D. N.D. 32,694 32,908 40,000 40,000 40,000 40,000 
miR-205 0,547 0,496 30,974 31,986 31,019 31,973 32,011 32,013 
miR-20b* 1,368 0,237 31,469 31,984 31,724 31,838 32,978 33,487 
miR-210 0,217 0,467 26,991 26,987 28,977 28,989 26,959 26,976 
miR-211 N.D. N.D. 31,979 31,977 40,000 40,000 40,000 40,000 
miR-24-2* 0,304 0,418 30,822 30,748 31,885 31,470 30,992 30,818 
miR-27a* 0,355 0,180 30,872 30,944 31,833 31,894 32,332 31,951 
miR-27b* 0,856 0,294 31,533 30,972 31,624 31,840 31,959 31,940 
miR-290-3p 1,675 0,126 24,954 25,991 25,977 24,970 27,951 28,982 
miR-290-5p 0,471 0,053 23,835 23,930 24,806 24,847 27,918 27,900 
miR-291a-3p 0,911 0,168 21,969 21,962 22,974 22,961 23,944 24,981 
miR-291a-5p N.D. N.D. 27,679 27,783 40,000 40,000 40,000 40,000 
miR-291b-3p 0,663 0,499 35,899 34,998 34,514 33,982 35,989 35,328 
miR-291b-5p 2,036 0,109 28,958 28,979 28,958 28,959 31,987 31,995 
miR-292-3p 1,043 0,145 19,951 19,940 20,974 20,970 22,963 22,963 
miR-292-5p 0,622 0,048 28,923 28,952 28,776 28,756 31,245 30,827 
miR-293 1,534 0,259 19,970 19,971 19,952 19,960 21,971 21,970 
miR-293* 0,054 0,135 32,447 32,993 40,000 33,185 34,977 34,987 
miR-294 1,279 0,191 22,954 23,985 23,987 23,979 25,982 25,971 
miR-294* 0,701 0,056 26,969 26,971 26,955 26,943 28,844 28,886 
miR-295 0,873 0,149 19,987 19,984 20,981 20,985 21,969 21,984 
miR-299* 0,899 0,342 30,887 30,137 30,931 30,930 31,024 30,836 
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miR-29a* 1,255 0,199 34,337 35,420 34,518 35,998 35,972 35,998 
miR-300 1,621 0,258 30,647 31,203 30,614 30,916 31,261 31,600 
miR-376b* 1,211 0,451 27,953 27,959 27,964 27,978 27,953 27,939 
miR-378* 0,901 0,367 33,974 33,955 33,969 33,963 34,973 32,955 
miR-429 0,488 0,153 25,970 25,969 27,982 28,000 28,988 28,989 
miR-449a 2,514 0,435 30,965 30,963 29,952 29,945 31,969 31,967 
miR-449c 1,067 0,410 34,337 32,870 33,284 33,634 33,807 35,989 
miR-465a-3p 2,055 N.D. 34,964 33,974 33,986 34,986 40,000 40,000 
miR-465b-5p 1,071 0,127 32,001 31,976 31,972 31,972 33,989 33,988 
miR-466a-3p 0,975 0,210 28,695 28,843 28,593 28,878 29,838 29,886 
miR-466b-3-3p 1,167 0,250 28,971 28,870 28,967 28,889 29,669 29,827 
miR-466d-3p 1,148 0,394 23,986 23,836 23,901 23,975 23,900 23,863 
miR-467a* 1,043 0,423 27,977 27,957 27,970 27,971 28,985 27,963 
miR-467b* 0,700 0,306 31,001 30,983 30,951 30,980 30,972 30,977 
miR-467e* N.D. N.D. 32,022 31,957 40,000 40,000 40,000 40,000 
miR-485* 0,645 0,082 26,972 26,965 27,990 27,987 29,981 29,969 
miR-489 0,916 0,183 29,969 29,961 30,983 30,975 31,956 31,946 
miR-665 1,859 0,377 30,983 31,991 30,985 31,003 30,984 32,001 
miR-672 0,649 0,133 26,967 26,952 27,953 27,951 28,961 28,954 
miR-673-5p 1,244 0,300 30,715 30,633 30,928 30,779 31,331 31,381 
miR-692 1,045 0,281 28,832 28,695 29,049 28,789 29,403 29,580 
miR-697 0,564 0,322 29,956 30,962 31,010 31,009 30,942 30,995 
miR-702 0,946 0,416 33,883 33,326 32,951 32,963 33,414 33,209 
miR-706 1,102 0,447 27,866 27,889 27,875 27,936 27,952 27,967 
miR-708 1,137 0,467 25,934 26,965 26,954 26,959 26,940 26,942 
miR-708* N.D. N.D. 34,985 33,978 40,000 40,000 40,000 40,000 
miR-715 N.D. N.D. 27,974 27,952 40,000 40,000 40,000 40,000 
miR-741 2,630 0,444 34,980 33,956 33,994 33,964 34,028 33,986 
miR-743b-3p N.D. N.D. 35,004 35,012 40,000 40,000 40,000 40,000 
miR-7a 0,922 0,345 29,963 30,968 30,974 30,966 31,978 31,972 
miR-7b 0,640 0,210 32,955 32,988 33,967 33,975 34,983 35,002 
miR-801 0,751 0,465 29,823 29,884 30,850 30,859 31,791 31,222 
miR-875-5p 0,652 0,274 33,230 33,461 32,843 34,834 33,739 35,445 
miR-878-3p 0,524 0,446 31,670 31,429 31,883 31,794 31,774 31,971 
miR-878-5p N.D. N.D. 35,958 35,951 40,000 40,000 40,000 40,000 
miR-881 0,547 N.D. 34,982 36,006 34,995 36,094 40,000 40,000 
miR-881* N.D. N.D. 34,010 34,978 40,000 40,000 40,000 40,000 
miR-92a* 1,821 0,230 29,982 29,989 28,969 28,966 30,989 30,982 
 
Table 1. microRNAs decreased upon the induction of ESC differentiation.  
Expression changes at 2 and 4 days of differentiation are calculated as fold change relative to 
undifferentiated ESCs. Ct are referred to two independent samples of undifferentiated (Ct ESCs) 
cells and two (Ct 2d) or four (Ct 4d) days differentiated ESCs. Cut off value was a fold change < 
0,50 at 4 days of differentiation. 
 58 
 
microRNA Ct ESCs Ct ESCs Ct 2d Ct 2d Ct 4d Ct 4d 
let-7c-1* 40,00 40,00 40,00 40,00 35,99 35,12 
miR-100 40,00 40,00 31,00 31,00 25,99 25,99 
miR-124* 40,00 40,00 30,75 31,40 29,88 29,48 
miR-125b* 40,00 40,00 33,97 35,96 32,11 32,86 
miR-125b-3p 40,00 40,00 40,00 40,00 34,96 33,97 
miR-133b 40,00 40,00 40,00 40,00 30,94 32,03 
miR-137 40,00 40,00 35,01 33,98 29,96 30,98 
miR-153 40,00 40,00 34,97 34,98 31,97 32,97 
miR-187 40,00 40,00 40,00 40,00 32,99 32,01 
miR-204 40,00 40,00 31,99 32,96 32,00 31,99 
miR-214* 40,00 40,00 40,00 40,00 34,07 34,00 
miR-216a 40,00 40,00 32,96 34,00 32,00 33,02 
miR-216b 40,00 40,00 31,98 32,98 29,96 29,95 
miR-217 40,00 40,00 33,95 33,94 31,98 30,99 
miR-219 40,00 40,00 32,00 31,96 27,95 27,97 
miR-302b* 40,00 40,00 32,78 32,04 40,00 40,00 
miR-325 40,00 40,00 40,00 40,00 31,97 30,97 
miR-325* 40,00 40,00 40,00 40,00 33,00 32,99 
miR-326 40,00 40,00 40,00 40,00 30,43 29,93 
miR-345 40,00 40,00 40,00 40,00 34,00 34,04 
miR-383 40,00 40,00 40,00 40,00 33,96 36,02 
miR-384-3p 40,00 40,00 40,00 40,00 31,98 31,99 
miR-486 40,00 40,00 40,00 40,00 29,97 30,00 
miR-598 40,00 40,00 40,00 40,00 31,98 34,01 
miR-684 40,00 40,00 40,00 40,00 35,01 35,97 
miR-743a 40,00 40,00 31,01 31,05 31,01 29,90 
miR-761 40,00 40,00 40,00 40,00 35,00 35,09 
miR-879 40,00 40,00 40,00 40,00 35,95 35,97 
miR-99a 40,00 40,00 30,96 31,99 25,00 25,98 
 
Table 2. microRNAs undetectable in undifferentiated ESCs and expressed 
upon the induction of the differentiation program.  
Ct are referred to two independent samples of undifferentiated (Ct ESCs) cells and two (Ct 2d) or 
four (Ct 4d) days differentiated ESCs. 
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microRNA 
2 days (fold 
change) 
4 days (fold 
change) 
Ct ESCs Ct ESCs Ct 2d Ct 2d Ct 4d Ct 4d 
miR-1 5,544 5,750 35,922 35,994 34,968 33,976 32,961 33,988 
miR-103 3,503 4,547 28,999 28,979 27,994 27,987 26,989 26,994 
miR-107 3,135 4,198 34,002 32,973 32,937 32,000 32,036 30,958 
miR-128a 5,037 2,383 33,971 32,982 31,972 31,962 31,967 31,974 
miR-129-3p 3,462 4,029 30,968 30,969 29,976 29,984 28,969 28,966 
miR-130a 2,599 2,576 25,958 25,967 25,971 25,972 24,966 24,960 
miR-130b 2,183 3,348 26,977 26,971 25,963 25,951 24,955 24,962 
miR-132 4,599 3,699 29,000 29,005 26,761 27,975 28,022 27,969 
miR-133a 3,875 7,243 31,983 31,997 29,968 29,989 28,980 28,986 
miR-135a 4,567 12,853 30,978 30,972 29,976 30,002 27,978 27,991 
miR-138 2,348 2,488 29,959 30,985 29,970 29,973 28,958 28,963 
miR-143 3,203 5,355 30,978 30,963 30,986 29,966 28,983 28,969 
miR-148b 3,245 2,563 32,978 32,970 31,984 31,947 31,965 30,961 
miR-149 2,241 2,001 27,929 27,930 26,932 26,951 25,854 25,899 
miR-151-3p 2,137 2,083 28,938 28,975 29,017 28,977 27,968 27,998 
miR-152 3,586 10,731 31,989 31,974 30,980 30,978 28,969 28,972 
miR-15a 2,845 3,767 29,013 28,984 27,988 27,971 26,989 26,961 
miR-15b 2,310 2,150 27,972 27,982 26,993 26,963 26,977 26,960 
miR-16* 6,704 3,102 34,701 35,037 32,423 32,949 32,814 32,760 
miR-181a-1* 5,921 21,844 34,205 33,492 32,635 32,649 30,821 30,225 
miR-185 2,485 3,261 31,967 31,989 30,979 30,958 29,981 29,974 
miR-18a 3,971 3,983 26,938 26,963 25,969 25,963 24,950 24,969 
miR-197 3,161 3,863 31,967 32,056 30,960 30,965 30,967 31,991 
miR-19b 2,918 2,300 18,977 19,985 18,991 18,966 17,945 18,070 
miR-218 2,161 9,587 27,940 27,955 27,962 27,953 24,956 24,967 
miR-218-2* 3,888 12,431 35,035 36,994 35,875 35,979 33,657 33,857 
miR-223 4,051 6,474 35,974 36,027 33,997 35,983 34,989 33,967 
miR-28 2,435 2,723 28,961 28,959 27,953 27,946 27,978 27,974 
miR-296-3p 2,974 2,905 29,964 30,997 28,981 29,993 28,988 28,975 
miR-298 3,782 4,031 27,966 28,982 26,964 26,949 26,966 26,988 
miR-301b 2,002 3,753 25,968 26,988 25,959 25,963 23,964 23,960 
miR-302a 7,537 3,926 24,956 25,962 22,959 22,958 22,953 22,957 
miR-302b 6,890 3,428 22,962 23,967 20,965 20,973 21,982 21,983 
miR-302c 6,734 4,133 28,018 27,982 26,990 26,997 25,965 26,994 
miR-302d 6,776 3,865 24,972 24,972 22,967 22,960 22,975 22,953 
miR-30b 2,146 2,828 26,980 26,982 25,972 25,981 24,974 24,968 
miR-30c 2,235 2,703 25,977 25,971 24,954 24,949 23,954 23,945 
miR-32 3,851 3,375 33,970 32,974 31,956 31,962 30,976 31,984 
miR-322 2,743 11,354 30,981 30,987 29,977 29,985 26,945 26,949 
miR-324-5p 3,231 5,210 30,941 30,940 29,950 29,946 28,963 28,970 
miR-328 10,429 13,193 32,959 31,968 29,977 30,973 28,977 28,969 
miR-330 2,325 3,836 32,016 32,947 36,023 30,977 30,998 30,993 
miR-331-3p 2,774 3,836 27,977 27,996 26,954 26,956 25,985 25,955 
miR-331-5p 7,329 4,346 32,972 33,955 31,985 32,993 31,995 31,970 
miR-335-3p 2,952 4,035 28,981 28,977 27,979 27,970 26,976 26,987 
miR-335-5p 5,634 15,634 29,953 29,980 27,953 28,967 25,958 25,985 
miR-339-5p 3,437 3,269 30,952 31,986 29,982 30,982 29,978 29,987 
miR-340-3p 2,929 6,898 31,958 33,970 31,960 31,974 29,959 29,963 
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miR-340-5p 3,751 7,799 29,967 30,999 29,988 28,970 27,967 27,965 
miR-342-5p 2,752 8,228 35,989 36,040 33,011 34,005 32,033 31,976 
miR-344 3,340 4,471 30,987 30,987 29,996 29,988 29,979 29,999 
miR-345-5p 2,988 4,386 32,040 31,971 31,969 30,982 30,991 29,967 
miR-34a 2,986 2,501 27,966 27,969 26,965 26,967 26,972 26,983 
miR-34c 3,498 7,576 32,985 32,986 30,981 32,970 30,972 30,979 
miR-350 3,537 5,012 32,980 32,990 31,979 31,970 30,981 30,968 
miR-351 4,143 10,921 30,971 31,980 30,974 30,987 29,989 29,989 
miR-362-3p 5,881 4,760 32,940 34,963 31,950 32,970 31,964 31,960 
miR-365 2,043 3,462 32,990 31,999 31,974 31,982 29,962 30,981 
miR-367 5,959 2,388 24,964 24,982 22,974 22,980 22,963 22,952 
miR-369-5p 4,368 2,380 30,950 30,961 29,968 28,948 29,967 29,968 
miR-370 5,852 2,815 27,973 27,964 26,977 26,970 26,977 26,990 
miR-380-5p 4,703 3,020 29,984 29,989 27,965 27,971 27,966 27,969 
miR-381 3,776 2,086 34,987 33,981 32,982 33,975 33,985 32,963 
miR-384-5p 7,847 40,479 31,931 32,979 30,971 29,953 26,947 26,943 
miR-409-5p 4,348 2,522 31,988 30,963 30,984 30,983 29,963 30,976 
miR-450a-5p 3,374 3,463 32,953 34,003 32,967 32,981 31,976 31,973 
miR-487b 4,385 2,008 28,976 29,992 27,970 27,973 27,961 27,966 
miR-493 13,656 6,504 33,984 35,005 32,989 32,967 32,959 32,992 
miR-500 2,071 3,775 31,977 31,963 31,990 30,972 30,976 30,972 
miR-503 3,468 11,252 30,984 30,999 29,990 29,970 27,967 27,980 
miR-503* 2,395 4,484 32,968 33,984 31,966 32,984 30,986 30,976 
miR-532-3p 2,478 2,506 30,998 30,980 29,980 29,981 28,984 30,004 
miR-532-5p 2,438 2,477 26,976 27,982 26,967 26,971 25,960 25,961 
miR-542-3p 2,901 2,183 34,980 33,976 33,986 33,982 32,967 33,983 
miR-574-3p 2,086 2,735 29,994 30,980 29,980 29,972 28,959 28,985 
miR-592 3,070 2,980 34,814 34,845 32,811 33,237 32,975 32,525 
miR-652 3,246 4,514 28,976 28,971 27,998 27,980 26,975 26,969 
miR-670 19,571 39,961 35,927 35,971 36,006 35,984 33,002 33,983 
miR-671-3p 28,445 14,740 35,971 35,997 32,988 32,998 32,988 32,999 
miR-676 2,812 2,186 30,994 30,993 29,946 30,986 29,973 29,972 
miR-701 5,245 11,319 35,923 36,037 35,994 33,964 33,851 33,355 
miR-744 2,859 3,695 29,970 29,954 28,948 28,953 27,953 27,957 
miR-744* 4,129 2,403 33,971 33,995 32,982 32,965 31,970 32,973 
miR-872 2,566 3,170 29,965 29,953 28,942 28,945 27,947 27,948 
miR-9 2,659 15,103 27,978 28,022 26,939 26,989 23,971 23,958 
 
Table 3. microRNAs increased upon the induction of ESC differentiation.  
Expression changes at 2 and 4 days of differentiation are calculated as fold change relative to 
undifferentiated ESCs. Ct in two independent samples of undifferentiated (Ct ESCs) cells and in 
cells grown for two (Ct 2d) or four (Ct 4d) days in differentiation conditions. Cut off value was an 
increase of at least two folds at 2 and 4 days of differentiation. 
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microRNA 
2 days (fold 
change) 
4 days (fold 
change) 
Ct ESCs Ct ESCs Ct 2d Ct 2d Ct 4d Ct 4d 
miR-106a 2,198 1,250 20,961 20,965 19,888 19,946 19,943 19,943 
miR-125a-3p 2,304 1,208 33,978 33,966 32,961 32,978 32,974 32,978 
miR-127 2,879 0,975 24,950 24,947 24,975 24,992 24,937 24,954 
miR-146a 2,087 1,731 29,983 29,983 28,968 28,970 28,982 28,972 
miR-148a 3,113 1,808 28,938 28,949 27,949 28,971 27,937 28,983 
miR-17 2,174 1,826 20,954 20,961 19,944 19,940 19,959 19,953 
miR-186 2,357 1,993 26,959 26,953 26,970 26,962 25,960 25,946 
miR-186* 2,952 1,616 31,465 30,938 29,734 29,840 29,843 29,849 
miR-18b 4,455 1,546 31,966 31,978 29,969 31,005 30,957 30,990 
miR-190 2,282 1,687 32,972 33,970 32,968 32,979 32,967 32,980 
miR-192 2,183 1,918 30,966 30,962 30,984 30,973 30,973 29,968 
miR-194 2,006 1,863 32,987 33,004 31,976 32,006 31,996 32,012 
miR-20b 2,289 0,820 21,959 21,961 20,939 21,957 21,945 21,947 
miR-21* 2,256 0,991 35,207 34,977 33,981 34,469 33,954 34,527 
miR-22* 2,182 1,025 32,741 32,887 31,883 31,822 31,933 32,280 
miR-29a 2,186 0,916 25,937 25,937 24,933 24,927 25,946 25,947 
miR-302a* 4,501 1,148 29,920 29,187 26,965 27,901 28,944 28,081 
miR-302c* 6,734 1,804 33,185 33,195 30,987 30,933 31,957 32,000 
miR-323-3p 3,324 1,540 25,971 25,977 24,963 24,972 25,978 25,982 
miR-337-3p 3,309 1,626 28,978 28,976 27,979 27,982 27,975 27,961 
miR-337-5p 3,347 1,442 28,959 29,979 27,959 28,987 28,979 28,977 
miR-34b-3p 2,355 1,730 29,967 29,959 29,970 29,976 29,985 29,979 
miR-363 3,531 1,485 28,973 28,967 27,960 27,967 27,959 28,986 
miR-369-3p 3,034 1,874 33,973 34,980 32,970 33,987 32,960 32,950 
miR-376a 2,793 1,496 27,980 27,986 26,995 26,982 26,989 26,981 
miR-376b 2,516 0,597 26,986 26,999 26,999 25,966 27,988 28,020 
miR-379 2,415 1,207 25,931 25,943 25,958 25,957 25,950 25,947 
miR-382 2,964 1,628 27,989 28,011 25,936 25,998 25,975 26,977 
miR-409-3p 2,002 0,655 23,955 24,973 23,961 23,951 24,957 24,965 
miR-410 2,599 1,188 26,969 26,962 25,960 25,945 25,939 25,938 
miR-411 2,041 1,004 24,956 24,957 24,975 24,978 24,965 24,967 
miR-431 2,815 1,300 24,975 24,969 23,969 23,974 23,958 23,964 
miR-433 2,663 1,256 28,967 28,964 28,972 28,975 28,968 28,968 
miR-434-3p 2,200 1,177 28,004 27,990 26,986 26,982 26,963 26,985 
miR-434-5p 3,529 1,324 30,991 30,983 28,987 29,989 29,982 29,984 
miR-467a 2,887 1,655 24,979 24,963 23,967 23,968 23,968 23,982 
miR-467b 2,034 0,986 27,987 27,986 26,955 26,966 27,979 27,992 
miR-467c 2,245 1,013 26,986 26,990 27,011 25,971 26,980 26,974 
miR-467d 2,182 1,300 28,968 28,964 28,976 28,981 27,961 27,951 
miR-467e 2,271 1,122 28,998 29,970 28,977 28,982 28,986 28,988 
miR-494 2,352 1,327 25,986 26,984 25,981 25,989 25,981 25,964 
miR-495 2,783 0,883 26,959 26,942 26,967 26,958 27,967 27,977 
miR-496 4,886 1,784 33,983 33,975 32,974 32,981 32,971 33,987 
miR-497 2,595 0,655 29,990 29,987 28,976 28,979 29,978 29,983 
miR-539 2,588 1,085 26,930 26,944 26,953 26,956 26,948 26,941 
miR-540-3p 3,142 0,772 29,995 29,993 28,966 28,972 29,982 29,992 
miR-543 2,528 0,588 28,964 28,968 28,979 28,977 29,974 29,971 
miR-544 2,771 1,583 31,980 31,968 30,972 30,949 30,959 31,975 
miR-667 2,704 1,453 27,961 27,967 27,979 27,973 27,993 27,990 
miR-669a 2,605 1,323 27,947 27,954 27,974 27,977 27,970 27,980 
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miR-673-3p 2,155 0,550 28,654 29,786 28,960 28,750 29,493 29,930 
miR-679 3,566 0,945 33,051 32,991 31,965 31,980 31,940 31,975 
miR-680 2,509 1,204 29,976 29,981 28,951 28,970 28,985 30,027 
miR-682 2,315 1,707 32,007 31,996 30,979 30,934 30,950 31,985 
miR-764-5p 2,672 0,737 33,831 33,897 32,876 32,987 33,996 33,134 
miR-96 2,647 0,848 30,976 31,971 30,995 30,965 31,985 31,996 
 
Table 4. microRNAs increased only at day 2 after the induction of ESC 
differentiation.  
Expression changes at 2 and 4 days of differentiation are calculated as fold change relative to 
undifferentiated ESCs. Cts are referred to two independent samples of undifferentiated (Ct ESCs) 
cells and two (Ct 2d) or four (Ct 4d) days differentiated ESCs. Cut off value was an increase of at 
least two folds at 2 days. 
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microRNA 
2 days 
(fold 
change) 
4 days 
(fold 
change) 
Ct ESCs Ct ESCs Ct 2d Ct 2d Ct 4d Ct 4d 
let-7c 1,521 2,144 34,985 33,977 33,970 34,972 32,956 32,946 
let-7e 0,791 4,900 32,971 33,004 32,977 34,006 30,972 29,959 
let-7i 1,969 2,086 32,004 32,985 31,982 31,999 32,009 31,997 
miR-106b 1,895 2,236 25,967 25,957 25,966 25,975 24,971 24,976 
miR-124 1,944 7,920 29,987 29,994 30,001 29,974 26,956 27,984 
miR-125b-5p 0,815 11,232 29,986 29,967 30,976 30,975 26,981 25,963 
miR-145 1,942 3,214 28,958 29,982 28,969 28,970 27,979 27,984 
miR-181a 1,228 26,300 32,991 32,927 31,957 33,965 28,987 28,994 
miR-190b 1,327 2,763 35,286 34,734 34,640 34,716 32,941 33,146 
miR-199a-3p 1,431 2,186 31,984 31,970 30,974 32,004 30,983 30,979 
miR-206 0,775 10,224 36,992 35,942 36,782 36,890 33,694 33,956 
miR-21 1,641 2,010 24,972 25,963 25,971 25,986 24,960 24,999 
miR-26b 1,816 2,212 27,969 27,973 27,955 27,972 26,967 26,966 
miR-301a 1,857 3,677 25,978 25,972 25,980 25,985 23,979 23,943 
miR-30d 1,629 2,119 28,973 28,991 28,986 28,981 27,960 27,981 
miR-322* 1,407 8,223 33,990 33,994 32,985 33,045 29,992 29,996 
miR-324-3p 1,452 2,684 29,982 30,039 30,015 30,003 28,976 28,990 
miR-455* 1,278 2,750 32,990 32,993 32,995 32,979 30,981 30,969 
miR-685 1,913 2,625 28,985 28,991 29,001 29,004 27,976 27,961 
miR-9* 1,000 3,613 30,974 30,967 30,964 30,967 28,982 27,966 
miR-93 1,915 2,419 24,967 24,964 23,946 23,944 22,942 22,950 
 
Table 5. microRNAs increased upon the induction of ESC differentiation only 
at day 4 after the induction of differentiation.  
Expression changes at 2 and 4 days of differentiation are calculated as fold change relative to 
undifferentiated ESCs. Ct are referred to two independent samples of undifferentiated (Ct ESCs) 
cells and two (Ct 2d) or four (Ct 4d) days differentiated ESCs. Cut off value was an increase of at 
least two folds at day 4. 
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microRNA microRNA microRNA microRNA microRNA microRNA 
let-7a miR-199a-5p miR-448 miR-488* miR-683 miR-759 
let-7b* miR-199b* miR-449b miR-490 miR-686 miR-762 
let-7d* miR-201 miR-450a-3p miR-499 miR-688 miR-764-3p 
let-7f* miR-202-5p miR-450b-5p miR-504 miR-691 miR-770-3p 
let-7f miR-207 miR-451 miR-505 miR-693-3p miR-802 
let-7i* miR-208 miR-452 miR-509-5p miR-693-5p miR-871 
miR-105 miR-208b miR-453 miR-511 miR-695 miR-873 
miR-10b* miR-214 miR-455 miR-547 miR-707 miR-874 
miR-10b miR-215 miR-463* miR-551b miR-710 miR-875-3p 
miR-122 miR-220 miR-464 miR-615-3p miR-711 miR-876-3p 
miR-133a* miR-23a miR-465a-5p miR-615-5p miR-712* miR-876-5p 
miR-139-3p miR-30c-2* miR-466c-5p miR-654-3p miR-713 miR-883a-3p 
miR-145* miR-330* miR-466d-5p miR-654-5p miR-717 miR-883a-5p 
miR-146b* miR-343 miR-466h miR-666-5p miR-718 miR-98 
miR-147 miR-346 miR-468 miR-668 miR-719  
miR-148a* miR-374* miR-469 miR-675-3p miR-742  
miR-150* miR-382* miR-470 miR-675-5p miR-743b-5p  
miR-188-3p miR-433* miR-483* miR-681 miR-758  
 
Table 6. microRNAs undetectable both in undifferentiated and differentiated 
ESCs. 
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microRNA 
2 days 
(fold 
change) 
4 days 
(fold 
change) 
Ct ESCs Ct ESCs Ct 2d Ct 2d Ct 4d Ct 4d 
let-7b 0,090 1,127 35,984 36,025 35,945 40,000 36,023 36,025 
let-7g 0,469 0,558 30,969 31,966 32,978 31,988 31,988 32,004 
miR-101a 1,904 1,889 29,973 29,974 28,938 29,986 28,985 28,984 
miR-101b 1,154 0,986 27,938 27,914 27,897 27,970 26,943 26,860 
miR-106b* 1,060 0,992 27,868 27,933 27,866 27,909 26,947 26,797 
miR-125a-5p 1,288 1,932 27,979 27,959 28,984 28,975 26,978 26,984 
miR-126-3p 1,585 0,858 25,961 25,965 27,001 26,986 26,992 26,981 
miR-126-5p 1,732 0,855 29,978 29,961 29,973 29,972 29,977 29,970 
miR-130b* 1,222 1,319 30,964 30,888 30,841 30,953 29,866 28,956 
miR-134 1,714 0,741 24,961 25,986 24,978 24,994 25,990 25,969 
miR-135a* 0,975 0,618 28,944 28,857 28,934 28,855 28,881 28,947 
miR-135b 1,403 0,809 24,977 24,972 24,959 24,987 24,973 24,973 
miR-136 1,588 0,647 26,983 26,954 26,958 27,996 27,967 27,985 
miR-138* 0,960 1,058 35,093 34,692 34,617 35,158 35,500 34,333 
miR-139-5p 0,982 0,541 29,967 30,973 30,966 30,975 30,984 30,970 
miR-140 1,969 1,693 26,963 26,975 25,947 25,946 25,954 25,968 
miR-146b 0,962 0,948 29,977 29,985 29,971 29,961 28,965 28,966 
miR-155 0,892 0,641 28,946 28,947 29,946 29,961 28,939 28,948 
miR-15a* 1,569 1,346 30,824 31,410 30,208 30,175 29,972 29,865 
miR-15b* 1,242 0,845 28,731 28,795 28,814 28,974 28,811 28,848 
miR-16 1,078 1,172 22,994 22,947 22,941 22,964 22,984 22,980 
miR-17* 0,917 0,576 31,168 31,435 31,913 31,815 31,338 30,857 
miR-181c 0,837 1,435 31,932 31,982 32,946 31,964 31,975 31,992 
miR-184 1,566 0,830 33,933 34,954 33,970 34,961 34,955 34,967 
miR-188-5p 1,867 1,238 30,945 30,933 30,956 30,948 30,945 29,928 
miR-18a* 0,920 0,624 30,925 30,946 30,712 30,918 30,909 30,214 
miR-191 1,180 1,099 24,000 23,975 23,962 23,972 24,005 23,986 
miR-191* 1,511 0,810 34,814 36,272 35,405 34,906 35,378 35,867 
miR-193* 0,850 1,091 34,124 35,314 35,417 34,696 33,586 33,889 
miR-193b 0,951 1,123 29,998 29,970 29,958 29,964 28,951 28,970 
miR-195 1,996 0,770 27,973 27,968 27,975 27,962 27,967 27,978 
miR-19a 1,971 1,846 22,983 22,972 21,963 22,983 21,975 21,967 
miR-203 1,271 0,650 29,975 29,974 29,957 29,968 29,962 30,976 
miR-20a 1,636 1,509 21,971 21,955 21,973 21,963 20,955 20,956 
miR-20a* 1,593 1,469 28,983 29,030 28,954 28,945 27,818 27,964 
miR-218-1* 0,255 1,681 35,956 35,041 35,817 35,300 34,727 35,639 
miR-22 1,091 1,070 28,904 28,924 28,986 28,984 28,980 28,991 
miR-221 1,346 1,785 28,957 28,973 28,989 28,969 29,001 28,990 
miR-222 0,772 0,747 26,943 26,944 27,946 27,956 26,938 26,941 
miR-224 1,439 1,224 31,973 31,987 31,983 31,972 30,966 30,960 
miR-23b 1,756 0,740 31,969 32,980 31,991 31,965 31,968 31,999 
miR-24 0,870 0,984 22,960 22,961 23,975 24,988 23,985 23,988 
miR-25 1,868 1,954 28,974 28,953 28,959 28,977 27,949 27,966 
miR-26a 1,456 1,718 25,965 25,969 25,961 25,965 24,963 24,949 
miR-26b* 1,357 1,246 33,392 32,564 33,423 32,928 32,181 31,566 
miR-27a 0,705 1,071 28,952 28,955 29,957 29,963 28,977 28,969 
miR-27b 1,478 1,158 28,942 28,946 29,962 29,957 28,952 28,958 
miR-28* 0,821 0,831 29,110 29,107 29,487 28,884 28,789 28,957 
miR-296-5p 1,641 1,002 27,995 27,941 28,016 27,975 28,000 27,964 
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miR-297a* 1,309 0,587 27,842 28,117 27,860 27,969 28,052 28,920 
miR-297b-5p 1,863 0,943 30,973 30,975 29,972 29,946 29,966 30,966 
miR-297c 1,747 1,060 31,052 30,984 30,016 29,995 29,955 29,971 
miR-29b 1,989 1,034 32,958 34,993 33,999 32,973 33,973 32,963 
miR-29c 1,969 1,072 29,988 29,978 29,975 29,982 28,979 29,974 
miR-300* 0,246 1,242 35,624 35,444 37,180 35,971 35,147 34,972 
miR-30a 1,495 1,806 27,928 28,970 28,962 28,961 27,952 27,956 
miR-30a* 1,069 1,609 27,867 27,917 27,965 27,762 25,926 25,915 
miR-30b* 0,993 1,339 33,475 33,319 32,688 32,178 32,422 32,763 
miR-30e 1,827 1,875 26,922 27,953 26,921 26,925 26,952 26,950 
miR-30e* 1,117 1,331 27,856 27,956 27,798 27,881 26,847 26,873 
miR-31 1,338 1,477 26,965 26,970 26,969 26,967 25,974 25,960 
miR-31* 1,238 1,099 28,983 28,992 28,992 28,972 27,975 27,967 
miR-320 1,432 0,726 28,970 28,972 28,975 28,976 28,965 28,959 
miR-329 1,986 1,912 32,969 32,955 32,971 31,946 31,971 31,966 
miR-33* 1,299 1,012 32,981 32,981 31,970 33,000 31,966 31,983 
miR-339-3p 0,959 0,687 29,001 29,989 29,055 29,988 30,013 29,016 
miR-342-3p 1,301 1,343 26,961 26,956 27,981 27,982 26,960 26,980 
miR-34c* 1,255 0,792 28,969 28,954 28,975 28,969 28,953 28,973 
miR-361 1,268 1,533 31,977 31,968 31,973 31,989 30,985 30,979 
miR-374 0,854 0,753 25,952 26,965 26,873 26,894 25,956 26,940 
miR-376a* 1,459 0,645 31,983 30,946 30,981 30,963 30,974 30,991 
miR-376c 1,939 1,055 25,963 25,965 25,976 25,985 25,974 25,972 
miR-378 1,298 0,693 26,036 25,944 25,933 25,855 25,839 25,885 
miR-380-3p 0,652 1,182 33,972 34,985 33,957 35,020 33,952 33,994 
miR-411* 1,162 0,575 30,973 31,048 31,989 31,976 31,982 31,978 
miR-425 1,385 0,906 27,946 27,984 28,035 27,973 27,972 27,946 
miR-425* 0,378 0,934 32,973 32,981 33,978 33,962 32,974 32,978 
miR-484 1,721 1,116 23,952 23,946 23,952 23,941 23,957 23,957 
miR-491 1,373 1,619 30,936 31,980 30,984 30,982 30,959 30,978 
miR-501-5p 0,003 0,528 33,984 33,979 40,000 40,000 32,983 32,962 
miR-542-5p 1,493 1,981 33,001 31,978 32,985 31,972 30,975 30,975 
miR-674 1,957 1,579 30,982 30,997 29,984 29,970 29,976 29,961 
miR-674* 1,681 1,360 28,978 28,973 28,980 27,967 27,972 27,980 
miR-676* 1,291 1,660 35,983 34,988 34,979 33,985 33,988 33,970 
miR-678 1,167 0,605 31,732 31,683 31,710 31,974 31,365 31,955 
miR-687 1,986 1,125 26,072 25,947 24,896 25,986 24,995 25,961 
miR-690 0,967 0,897 23,982 23,955 23,942 23,967 23,967 23,932 
miR-694 1,608 0,748 33,649 33,144 33,266 33,616 33,281 32,541 
miR-696 1,359 0,589 25,802 26,972 26,689 26,956 26,725 26,913 
miR-699 0,756 0,525 25,974 25,982 26,967 26,925 25,937 25,873 
miR-700 1,100 0,644 29,778 29,774 29,347 29,782 29,764 29,701 
miR-704 1,408 1,060 32,275 32,800 32,243 32,461 31,773 31,855 
miR-709 1,283 0,633 22,914 22,945 22,963 22,953 22,925 22,939 
miR-720 1,055 0,655 23,871 23,937 23,964 23,960 23,954 23,986 
miR-760 1,660 1,360 30,920 30,920 29,813 30,928 29,607 29,865 
miR-7a* 1,175 0,630 28,972 28,980 28,987 27,961 27,957 27,968 
miR-804 0,939 0,866 33,046 32,961 33,121 33,934 32,483 32,312 
miR-805 0,710 0,505 25,929 25,821 26,831 26,687 25,867 25,648 
miR-872* 0,998 1,445 28,971 28,956 28,953 28,958 27,964 27,971 
miR-877 1,108 0,722 31,235 30,960 31,859 30,957 30,849 30,734 
miR-877* 1,295 0,566 29,987 28,980 29,000 29,006 28,989 29,004 
miR-92a 1,821 0,804 23,939 23,950 23,951 23,947 24,962 24,963 
miR-93* 1,348 1,142 26,955 26,949 26,962 26,960 25,955 25,956 
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miR-99b 1,758 1,995 26,983 26,958 26,943 26,992 25,972 25,995 
miR-99b* 1,109 1,478 32,998 33,001 32,989 32,992 30,972 30,987 
         
Table 7. microRNAs unchanged upon the induction of ESC differentiation.  
Expression changes at 2 and 4 days of differentiation are calculated as fold change relative to 
undifferentiated ESCs. Cts are referred to two independent samples of undifferentiated (Ct ESCs) 
cells and two (Ct 2d) or four (Ct 4d) days differentiated ESCs. Cut off value was a fold change < 2 
at day 2 of differentiation and  < 2 but > 0,50 at 4 days of differentiation. 
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Target microRNA 
ABCD4 miR-340-5p 
ABCG4 miR-9, miR-322, miR-218, miR-133a, miR-15a, miR-132, miR-32, miR-185, miR-145, miR-370, miR-93, miR-
367, miR-106b, miR-15b, miR-25, miR-17, miR-20a, miR-137, miR-133b, miR-217 
ADAM23 miR-32, miR-367, miR-25 
AES miR-124 
ARID5B miR-384-5p, miR-124, miR-302a, miR-302d, miR-301b, miR-301a, miR-302b, miR-32, miR-130b, miR-30b, 
miR-30c, miR-130a, miR-367, miR-30d, miR-25, miR-101a, miR-30e, miR-30a 
B3GNT1 let-7e, let-7c, let-7i 
BCAT2 miR-9, miR-135a, miR-32, miR-367, miR-25 
BCLAF1 miR-384-5p, miR-181a, miR-9, miR-362-3p, miR-330, miR-339-5p, miR-30b, miR-30c, miR-30d, miR-329, miR-
30e, miR-30a, miR-219, miR-326 
BRP44L miR-124, miR-302a, miR-302d, miR-302b, miR-137, miR-217 
BSPRY miR-32, miR-367, miR-25 
CACNB4 miR-340-5p 
CACYBP miR-384-5p, miR-30b, miR-30c, miR-30d, miR-30e, miR-30a 
CALML4 miR-135a, miR-218, miR-223, miR-296-3p, miR-138 
CHCHD4 miR-152, miR-148b, miR-148a 
CREB1 miR-181a 
CTBP2 miR-206, miR-133a, miR-1, rno-miR-1, miR-101a, miR-133b 
CTH miR-384-5p, miR-322, miR-15a, miR-30b, miR-30c, miR-15b, miR-30d, miR-30e, miR-30a 
DEF6 miR-124 
DERL3 miR-330, miR-326 
DTX1 miR-138, miR-204 
EED miR-384-5p, miR-181a, miR-30b, miR-30c, miR-30d, miR-101a, miR-30e, miR-30a 
EEF1E1 miR-204 
EFHC2 miR-137 
EGLN3 miR-9, miR-218, miR-301b, miR-301a, miR-130b, miR-130a, miR-93, miR-106b, miR-17, miR-20a 
EIF4A2 miR-181a, miR-132, miR-19b, miR-19a 
ELAVL2 miR-181a, miR-9, miR-152, miR-340-5p, miR-302a, miR-302d, miR-302b, miR-148b, miR-19b, miR-26b, miR-
542-3p, miR-19a, miR-148a, miR-26a, miR-140, miR-486, miR-216a, miR-153, miR-217, miR-383 
ENAH 
miR-384-5p, miR-181a, miR-335-5p, miR-9, miR-322, miR-124, miR-340-5p, miR-302a, miR-302d, miR-330, 
miR-15a, miR-301b, miR-301a, miR-365, miR-302b, miR-130b, miR-30b, miR-30c, miR-130a, miR-19b, miR-
542-3p, miR-15b, miR-30d, miR-186, miR-101a, miR-30e, miR-194, miR-19a, miR-30a, miR-544, miR-216b, 
miR-204, miR-326, miR-384-3p, miR-153, miR-217, miR-383 
EPS8 miR-218, miR-124, miR-365, miR-32, rno-miR-381, miR-367, miR-381, miR-25, miR-216b, miR-137, miR-204 
FGF4 miR-93, miR-106b, miR-17, miR-20a 
FN1 miR-101a 
FOXD3 rno-miR-381, miR-381, miR-382 
FZD4 
miR-152, miR-218, miR-124, let-7e, miR-103, miR-107, miR-330, miR-301b, miR-301a, miR-130b, miR-145, 
miR-130a, miR-148b, miR-93, miR-106b, let-7c, let-7i, miR-101a, miR-194, miR-17, miR-148a, miR-496, miR-
20a, miR-219, miR-326, miR-216a 
GCLM miR-9, miR-32, miR-145, miR-367, miR-186, miR-25 
GFPT2 miR-384-5p, miR-124, miR-340-5p, miR-32, miR-30b, miR-30c, rno-miR-381, miR-367, miR-30d, miR-381, 
miR-25, miR-30e, miR-30a, miR-153 
GLDC miR-384-5p, miR-30b, miR-30c, miR-30d, miR-30e, miR-30a 
GNPNAT1 miR-9, miR-206, miR-1, miR-103, miR-107, rno-miR-1, miR-26b, miR-26a 
GSTM3 miR-145 
GSTT2 miR-137 
GTF2H1 miR-384-5p, miR-152, miR-301b, miR-301a, miR-130b, miR-30b, miR-30c, miR-130a, miR-148b, miR-30d, 
miR-30e, miR-148a, miR-30a 
HAT1 miR-486 
HELLS miR-384-5p, miR-34c, miR-30b, miR-30c, miR-34a, miR-30d, miR-30e, miR-30a 
HK2 miR-9, miR-125b-5p, miR-351, rno-miR-351, miR-143, let-7e, miR-19b, let-7c, let-7i, miR-125a-5p, miR-19a 
ICAM1 miR-125b-5p, miR-351, rno-miR-351, miR-125a-5p 
INA miR-34c, miR-592, miR-34a, miR-138  
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JARID1B miR-18a, miR-132, rno-miR-381, miR-381, miR-194, miR-18b, miR-137 
JARID2 
miR-384-5p, miR-181a, miR-322, miR-503, miR-152, miR-206, miR-1, miR-15a, miR-301b, miR-301a, miR-32, 
miR-130b, miR-30b, rno-miR-1, miR-30c, miR-130a, miR-148b, miR-138, miR-367, miR-19b, miR-26b, miR-
15b, miR-30d, miR-25, miR-30e, miR-19a, miR-148a, miR-30a, miR-26a, miR-544, miR-204, miR-153 
JMJD1A miR-384-5p, miR-30b, miR-30c, miR-30d, miR-30e, miR-30a 
KLF4 miR-135a, miR-152, miR-124, miR-103, miR-107, miR-32, miR-145, miR-148b, rno-miR-381, miR-367, miR-
26b, miR-381, miR-25, miR-148a, miR-146a, miR-26a, miR-137 
KLF5 miR-9, miR-152, miR-143, miR-145, miR-148b, miR-21, miR-148a, miR-153 
LAPTM5 miR-219 
LRAT miR-206, miR-218, miR-1, miR-362-3p, rno-miR-1, miR-329 
LRBA miR-181a, miR-223 
LRRC2 miR-133a, miR-26b, miR-26a, miR-133b 
MAT2A 
miR-384-5p, miR-124, miR-340-5p, miR-30b, miR-30c, miR-26b, miR-30d, miR-30e, miR-30a, miR-26a, miR-
153 
MCF2 miR-218, miR-124, miR-143 
MGA miR-181a, miR-9, let-7e, miR-103, miR-107, let-7c, let-7i, miR-216a, miR-383 
MKRN1 miR-384-5p, miR-302a, miR-302d, miR-302b, miR-30b, miR-30c, miR-93, miR-19b, miR-106b, miR-30d, miR-
30e, miR-19a, miR-17, miR-30a, miR-20a 
MRAS miR-135a, miR-152, miR-206, miR-34c, miR-1, miR-362-3p, rno-miR-1, miR-148b, miR-34a, miR-138, miR-
26b, miR-329, miR-148a, miR-26a 
MSC miR-149 
MTF2 miR-181a, miR-138, miR-186, miR-153 
MYB miR-322, miR-503, miR-15a, miR-301b, miR-301a, miR-130b, miR-130a, miR-15b, miR-153 
MYBL2 miR-384-5p, miR-143, miR-30b, miR-30c, miR-30d, miR-30e, miR-30a 
MYNN miR-103, miR-107, miR-93, miR-106b, miR-17, miR-20a 
MYST4 miR-328, miR-135a, miR-340-5p, rno-miR-381, miR-381, miR-101a 
NCL miR-206, miR-1, rno-miR-1 
NEFH miR-32, miR-367, miR-25, miR-137 
NFYB miR-384-5p, miR-335-5p, miR-340-5p, miR-197, miR-32, miR-30b, miR-30c, rno-miR-381, miR-367, miR-30d, 
miR-381, miR-25, miR-30e, miR-30a, miR-221, miR-544, miR-216b, miR-137 
NME7 miR-301b, miR-301a, miR-130b, miR-130a, miR-19b, miR-19a 
NOL8 miR-181a 
NR5A2 
miR-384-5p, miR-9, miR-30b, miR-30c, rno-miR-381, miR-30d, miR-381, miR-186, miR-30e, miR-30a, miR-
216a 
NRP2 miR-322, miR-15a, rno-miR-381, miR-15b, miR-381, miR-149 
NUP35 miR-301b, miR-301a, miR-130b, miR-130a, rno-miR-381, miR-93, miR-106b, miR-381, miR-17, miR-20a 
OTX2 miR-152, miR-206, miR-1, miR-301b, miR-301a, miR-130b, miR-145, rno-miR-1, miR-130a, miR-148b, miR-
148a, miR-219, miR-153 
PADI2 miR-330, miR-137, miR-326 
PARP16 miR-384-5p, miR-328, miR-124, miR-30b, miR-30c, miR-30d, miR-30e, miR-30a, miR-761 
PAX6 rno-miR-190b, miR-365, miR-190b, miR-190 
PCOLCE2 miR-32, miR-367, miR-25 
PDCD10 miR-384-5p, miR-206, miR-1, miR-103, miR-107, miR-30b, rno-miR-1, miR-30c, miR-26b, miR-30d, miR-186, 
miR-30e, miR-30a, miR-26a 
PECAM1 miR-26b, miR-26a 
PFKP miR-302a, miR-302d, miR-302b, miR-93, miR-106b, miR-17, miR-20a 
PHC1 miR-340-5p, miR-324-5p, miR-149, miR-186 
PIGA 
miR-384-5p, miR-328, miR-152, let-7e, miR-302a, miR-302d, miR-301b, miR-301a, miR-302b, miR-130b, miR-
30b, miR-30c, miR-130a, miR-148b, let-7c, miR-30d, let-7i, miR-30e, miR-148a, miR-30a, miR-361, miR-486, 
miR-153 
PLA2G10 miR-19b, miR-19a 
PML miR-124, miR-133a, miR-149, miR-133b 
PMM1 miR-322, miR-15a, miR-15b 
POU5F1 miR-335-5p, miR-491 
PSAT1 miR-145 
PTP4A3 miR-18a, miR-140, miR-18b, miR-137 
QDPR miR-124 
RARG miR-384-5p, miR-124, miR-143, miR-330, miR-30b, miR-28, miR-30c, miR-30d, miR-30e, miR-30a, miR-326 
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RFX2 miR-384-5p, miR-30b, miR-30c, miR-30d, miR-30e, miR-30a 
RIF1 miR-340-5p, rno-miR-381, miR-381 
RNF125 miR-181a, miR-322, miR-124, miR-340-5p, miR-103, miR-107, miR-15a, miR-15b, miR-186, miR-101a, miR-
140, miR-486, miR-204, miR-384-3p 
RNF138 miR-135a, miR-322, miR-503, miR-206, miR-1, miR-15a, rno-miR-1, miR-26b, miR-15b, miR-149, miR-186, 
miR-26a, miR-137, miR-204, miR-216a 
RNMT 
miR-384-5p, miR-181a, miR-223, miR-362-3p, miR-103, miR-107, miR-30b, miR-30c, miR-30d, miR-329, miR-
30e, miR-30a 
RPS16 miR-340-5p 
SDAD1 miR-384-5p, miR-30b, miR-30c, miR-30d, miR-30e, miR-194, miR-30a, miR-761 
SFRS3 miR-135a, miR-206, miR-1, rno-miR-1, miR-21, miR-486 
SFRS7 miR-384-5p, miR-181a, miR-30b, miR-30c, miR-30d, miR-30e, miR-30a, miR-216b 
SHMT1 miR-218, miR-330, miR-326 
SIRT1 miR-384-5p, miR-181a, miR-9, miR-135a, miR-133a, miR-30b, miR-30c, miR-138, miR-30d, miR-30e, miR-
30a, miR-204, miR-133b, miR-217 
SLC25A5 miR-137 
SLC29A1 miR-124 
SMAD7 miR-181a, miR-322, miR-503, miR-340-5p, miR-15a, miR-32, miR-93, miR-367, miR-106b, miR-15b, miR-21, 
miR-25, miR-17, miR-20a, miR-216a 
SMARCA5 miR-384-5p, miR-30b, miR-30c, miR-30d, miR-99b, miR-101a, miR-30e, miR-30a, miR-100, miR-99a 
SNX10 miR-384-5p, miR-30b, miR-30c, miR-30d, miR-30e, miR-30a 
SOCS2 miR-101a, miR-194, miR-153 
SOCS3 miR-384-5p, miR-181a, miR-152, miR-218, miR-124, miR-340-5p, miR-30b, miR-30c, miR-148b, miR-19b, 
miR-30d, miR-30e, miR-19a, miR-148a, miR-30a, miR-221, miR-383 
SPOCK2 miR-181a, miR-124, miR-340-5p, miR-32, miR-367, miR-26b, miR-25, miR-26a, miR-137 
SPP1 miR-181a 
SPRY2 miR-340-5p, miR-21, rno-miR-758 
SPRY4 miR-181a, miR-322, miR-133a, miR-15a, rno-miR-381, miR-93, miR-19b, miR-106b, miR-15b, miR-381, miR-
19a, miR-17, miR-140, miR-20a, miR-133b 
SRM miR-340-5p 
SSTR1 miR-149 
STMN1 miR-101a 
STOML1 miR-384-5p, miR-30b, miR-30c, miR-30d, miR-30e, miR-30a 
SYCP3 miR-137 
SYNGR1 miR-218, miR-197, miR-370 
TCEA3 miR-186 
TCF15 miR-132 
TFRC miR-9, miR-152, miR-124, miR-34c, miR-145, miR-148b, miR-34a, miR-194, miR-148a, rno-miR-758, miR-544 
TLE4 miR-322, miR-503, miR-124, miR-103, miR-107, miR-302a, miR-302d, miR-15a, miR-302b, miR-93, miR-106b, 
miR-15b, miR-17, miR-20a, miR-761 
TNFSF11 miR-93, miR-106b, miR-17, miR-20a 
TRIM2 
miR-181a, miR-9, miR-322, miR-206, miR-1, miR-18a, miR-302a, miR-302d, miR-15a, miR-301b, miR-301a, 
miR-302b, miR-130b, miR-339-5p, miR-145, rno-miR-1, miR-130a, miR-19b, miR-15b, miR-19a, miR-18b, miR-
204, miR-761 
TRIM25 miR-9, miR-186, miR-544 
TWISTNB miR-340-5p 
UBTF miR-145, miR-370, miR-26b, miR-101a, miR-26a, miR-382 
UBXD4 miR-93, miR-106b, miR-17, miR-20a 
VEGFC miR-137 
WDR35 miR-221, miR-544 
XBP1 miR-32, miR-367, miR-25 
XRCC5 miR-340-5p 
ZFP42 miR-186, miR-384-3p  
    
Table 8. TargetScan prediction.  
List of genes down-regulated during ESC differentiation and predicted target  all UP-regulated 
microRN
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Discussion 
microRNAs function as fine regulators of gene expression and they have been 
implicated in the maintenance of ESC phenotype and in modulation of their 
differentiation program. Several microRNAs expressed in mammalian ESCs have 
been cloned (Calabrese, Seila et al. 2007; Babiarz, Ruby et al. 2008) and mouse 
ESC specific microRNAs have been described (Houbaviy, Murray et al. 2003). 
However their function, particularly at early stages of ESC differentiation, has not 
been reported so far, even if it was demonstrated that ESCs lacking Dicer or 
Drosha, and therefore most mature microRNAs do not differentiate into most 
lineages (Kanellopoulou, Muljo et al. 2005; Murchison, Partridge et al. 2005; 
Chang, Wentzel et al. 2007). Several factors complicate the identification and the 
functional characterization of microRNAs during ESC differentiation. In fact, the 
expression profile of microRNAs strictly depends on the differentiation program 
occurring. Moreover, considering that microRNAs exhibit a high degree of stage- 
and tissue-specificity, it is likely that those operating during narrow windows of 
differentiation, that is those controlling the balance between self-renewal and 
differentiation, may be under-represented in the current databases. So the 
complete picture of the microRNAs involved in ESC functions and especially their 
roles in the regulation of ESC fate have to be further investigated.  
In this study we reported a systematic analysis of microRNA expression profile in 
undifferentiated and differentiating mouse ESCs. Briefly to perform our profiling 
experiments we collected RNA samples from undifferentiated and two and four 
day differentiated ESCs and then we performed a TaqMan analysis. The choice of 
time points at which to collect RNA samples during the course of differentiation is 
a crucial point for a microRNA profiling experiment. In fact, individual microRNAs 
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can show dynamic changes during ESC differentiation, and therefore the profiling 
of microRNA expression before and after differentiation would only allow 
assessment of ultimate changes, thereby precluding identification of microRNAs 
expression changes during differentiation. So to identify microRNAs controlling the 
balance between self-renewal and differentiation of ESCs we proceeded with the 
examination of the microRNA expression at two early differentiation time points.  
We did not choose to use retinoic acid (RA) to induce differentiation but a different 
protocol that induced a slower and more physiological differentiation, mainly into 
neurons.  
Another important issue needs to be addressed regarding microRNA expression 
profiling. The latter is an important tool for the identification of differentially 
expressed microRNAs but remains a technical challenge for high-throughput 
microRNA expression analysis, because the number of microRNAs continues to 
increase with in silico prediction and experimental verification. So the choice of an 
advanced microRNA expression profiling approach, as the quantitative RT-PCR 
array (qPCR-array), rather than oligonucleotide microchip (microarray), is 
fundamental. In fact, comparison between microarray and qPCR-array indicated 
superior sensitivity and specificity of qPCR-array, which has also higher 
reproducibility and a lower false positive rate of differential microRNA expression 
(Chen, Gelfond et al. 2009). These previous observations suggested us to use the 
quantitative RT-PCR approach for our microRNA profiling.  
Comparison of the expression profiles between undifferentiated ESC and 
differentiating cells allowed us to classify microRNAs in five groups: (1) 
microRNAs decreased upon the induction of ESC differentiation; (2) microRNAs 
undetectable in undifferentiated ESCs and expressed upon the induction of the 
differentiation program; (3) microRNAs expressed in ESCs and increased upon 
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the induction of ESC differentiation; (4) microRNAs undetectable both in 
undifferentiated and differentiated ESCs; (5) microRNAs unmodified upon the 
induction of differentiation. 
The analysis of groups of microRNAs whose profiling was already described in 
ESCs allows us to verify that there was a high degree of coherence between our 
microRNA expression data and published data. Indeed in the group of microRNAs 
decreased upon the induction of ESC differentiation we have found miR-290 
cluster well known to be ESC-specific and to have key functions in stemness 
maintenance such as DNA methylation and proliferation control (Sinkkonen, 
Hugenschmidt et al. 2008). Also miR-200 family is an ESC specific family of 
microRNAs (Calabrese, Seila et al. 2007) that we found to be strongly decreased 
upon induction of ESC differentiation. These results were in agreement with Lin 
and co-workers, which demonstrated that overexpression of the members of this 
microRNA family (miR-200a, miR-200b, miR-200c, miR-141 and miR-429) was 
most effective in retarding stemness marker loss after LIF removal, while their 
knockdown facilitated differentiation (Lin, Jackson et al. 2009). In the group of 
microRNAs undetectable in undifferentiated ESCs and expressed upon the 
induction of the differentiation program we reported 29 microRNAs. Some of them 
(miR-100, miR-137, miR-204, miR-383 and miR-99a) were already described to be 
undetectable in ESCs (Calabrese, Seila et al. 2007). Earlier studies had reported 
that miR-135 and miR-124 regulate neurogenesis during central nervous system 
(CNS) development (Cao, Pfaff et al. 2007; Visvanathan, Lee et al. 2007). 
Accordingly we have classified these two microRNAs belong to our group of 
strongly increased microRNAs upon induction of ESC differentiation. In the same 
group we listed also miR-9, well known to modulate ESC-derived neurogenesis 
(Krichevsky, Sonntag et al. 2006). 
 74 
Furthermore Smirnova and co-workers demonstrated that mir-23, miR-26 and 
miR-29 were more strongly expressed in astrocytes than neurons (Smirnova, 
Grafe et al. 2005).  
In our differentiating ESCs miR-23b, miR-26a, miR-29b and miR-29c displayed a 
fold induction lower than our cut off value (fold increase<2), so we classified them 
in the group of microRNAs whose expression was unchanged during ESC 
differentiation.  On the other hand, miR-26b and miR-29a were increased upon 
differentiation with a fold induction just a bit higher than the cut off value. These 
results are in agreement with Smirnova and co-workers. Indeed our differentiation 
protocol produced mainly neurons and only a small fraction is represented by 
astrocyte differentiated cells.   
The let-7 family is comprised of 12 family members (let-7-a1, a2, a3, b, c, d, e, f1, 
f2, g, i and miR-98), known to be strongly induced during ESC neural 
differentiation and in brain (Wulczyn, Smirnova et al. 2007). However, we found 
only three members (let7-c, let-7e and let-7i) of this family in our up-regulated 
microRNAs and we observed an increase of the expression profile of these 
specific microRNAs only at day 4 of differentiation. Nevertheless, because we 
focused our analysis to the early phase of differentiation our data were consisting 
with the previous description of let-7 family as late expressed microRNA family in 
mammalian embryonic development.  
We found a good degree of congruity between our data and published data also in 
the case of miR-302 cluster (all miR-302 family and miR-367), belonging to the 
group of microRNAs increased upon ESC differentiation induction (Ciaudo, 
Servant et al. 2009).  
miR-17 family consists of 14 mature microRNAs (miR-17, miR-18a, miR-18b, miR-
19a, miR-19b, miR-20a, miR-20b, miR-25, miR-92a and 92b, miR-93, miR-106a 
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and miR-106b), expressed as three polycistronic clusters. According to us Foshay 
and collaborators reported that some members of this family (miR-17, miR-20a, 
miR-93, and miR-106a) are expressed in ESCs and increased upon induction of 
differentiation (Foshay and Gallicano 2009). We found a very similar profile also 
for the other members of this family, which are significantly expressed in 
undifferentiated cells and their expression appreciably increased during 
differentiation. Previously, these microRNAs have been considered ESC-specific 
for their abundance in undifferentiated ESCs and in some cases for their reduction 
in differentiated ESCs (Houbaviy, Murray et al. 2003; Calabrese, Seila et al. 2007). 
However a very recent work demonstrated that their expression persisted or 
increased upon ESC differentiation according to our results (Ciaudo, Servant et al. 
2009). Differences in the ESC line and in differentiation protocol used could 
explain these discrepancies.  
In our data miR-21 followed the expression profile of miR-17 cluster microRNAs. 
miR-21 is expressed in ESCs and its expression appreciably increased in ESC 
differentiating derivatives. This is in agreement with the role of miR-21 recently 
described as inhibitor of self-renewal and pluripotency of ESCs through 
suppression of Nanog, Sox2 and possibly Oct3/4 stemness genes (Singh, 
Kagalwala et al. 2008). 
Finally, in the group of microRNAs undetectable both in undifferentiated and 
differentiated ESCs we found some microRNAs already described to be absent in 
undifferentiated ESCs such as miR-122, miR-208, miR-214, miR-215, miR-451, 
miR-452, miR-551b, miR-675 and miR-693 (Calabrese, Seila et al. 2007). 
Notably, in our study we reported that a large number of microRNAs are increased 
upon the induction of differentiation. For some of them we also performed a 
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systematically identification of the mRNA targets by integrated experimental and 
bioinformatics approaches.  
We focused on the group of up-regulated microRNAs because the role of 
microRNAs in undifferentiated ESCs is enough established compared with their 
possible role in assisting ESC differentiation. We reasoned that for ESC-derived 
cell types it is equally critical to suppress genes necessary to maintain ESCs in the 
undifferentiated state as well as to suppress genes driving differentiation toward 
alternative fates. While this occurs at the transcriptional level, it is possible that 
microRNAs contribute to this process by clearing expressed mRNAs that 
antagonize newly adopted fate. Moreover, the identification of targets of these 
microRNAs will contribute to a more detailed knowledge of the molecular 
mechanisms of ESC differentiation and may provide tools to direct ESC 
differentiation towards specific lineages.  
We focused on three of these up-regulated microRNAs, miR-100, miR-137 and 
miR-34a, whose candidate targets are downregulated upon ESC differentiation, 
and we provided evidence that these microRNAs are necessary for proper 
differentiation of ESCs.  
Several groups associated miR-100 and cancer. miR-100 can act either as a 
tumor suppressor (Nagaraja, Creighton et al. 2010) or as oncogene (Ueda, Volinia 
et al. 2009). However, its role in cell differentiation is completely unknown. It 
belongs to miR-99 microRNA family that comprises other two more members: 
miR-99a and miR-99b. miR-100 and miR-99a are very similar in nucleotide 
sequence, indeed differ only for one nucleotide (Figure 33), so they also share 
candidate targets (http://www.mirbase.org/).  
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Figure 33. Nucleotide sequence of miR-99 family member.  
In yellow are evidenced the differences in nucleotide sequences between the three microRNAs. 
 
miR-100 and miR-99a are undetectable in undifferentiated ESCs, accumulate 
starting from day 2 after the induction of differentiation and reach robust levels of 
expression at day 4 of differentiation. Instead miR-99b is already present in 
undifferentiated ESCs and increases when differentiation occurs. We 
demonstrated that Smarca5 is a new direct target for miR-100. Of course, the 
biological effects observed in cells where this microRNA was silenced could be 
also due to the targeting of other still unknown mRNAs. Similarly to miR-100, miR-
137 is undetectable in undifferentiated ESCs, appears at day 2 and significantly 
increases after 2 more days of differentiation. Also in this case we have identified 
a new target for this microRNA, Jarid1b. miR-137 is a tumor suppressor 
microRNA; it was downregulated in human oral cancers and its re-expression 
blocks tumor cell proliferation (Kozaki, Imoto et al. 2008). The possible role of miR-
137 in the regulation of cell differentiation is also supported by the observations 
that its overexpression induces the differentiation of mouse neural stem cells and 
of other stem cells derived from oligodendroglioma or glioblastoma multiforme 
(Silber, Lim et al. 2008). 
miR-34a is a well known microRNA, whose involvement in various cellular 
functions is well documented and whose role as tumor suppressor is widely 
accepted (Chang, Wentzel et al. 2007). It belongs to miR-34 family that comprises 
miR-34a, miR-34b and miR-34c members that are all microRNAs induced upon 
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ESC differentiation. It was previously demonstrated that miR-34a targets Sirt1 
(Yamakuchi, Ferlito et al. 2008) and is regulated by p53 (Hermeking 2010), which, 
in turn, is activated by Sirt1 suppression. The induction of miR-34 upon ESC 
differentiation and the concomitant decrease of Sirt1 (Figure 15 and (Loh, Wu et 
al. 2006)), suggest that p53 could be activated through this mechanism and this 
hypothesis is in agreement with the demonstration that p53 represses Nanog gene 
transcription, thus favoring ESC differentiation (Lin, Chao et al. 2005). Another not 
alternative mechanism through which miR-34a may influence ESC differentiation 
could be based on the downregulation of Wnt1, which was recently demonstrated 
to be a target of miR-34a (Hashimi, Fulcher et al. 2009). Wnt1 is required to 
maintain long-term mouse ESC pluripotency (Miyabayashi, Teo et al. 2007) and 
differentiation of ESCs is accompanied by a significant downregulation of Wnt1 
protein level (Sampath, Pritchard et al. 2008). Also in this case, miR-34a-
dependent targeting of Wnt1 could contribute to drive differentiation of ESCs.  
We obtained strong evidence that the suppression of these three microRNAs, we 
have characterized, is necessary for proper differentiation of mouse ESCs. In fact, 
their suppression impairs ESC differentiation in vitro (Figure 30) and in vivo 
(Figure 32). On the basis of these results we proposed a key role for microRNAs 
that overcomes their function as modulators. Indeed, it becomes increasingly 
evident that microRNAs play a fundamental and irreplaceable role in the regulation 
of the biological processes, including ESC fate and behavior. So it becomes 
indispensable also to study also the mechanisms that control their expression at 
transcriptional level. We identified Smarca5, Jarid1b and Sirt1 as target of miR-
100, miR-137 and miR-34a, respectively, but it is important to identify other 
possible targets of these and other microRNAs to verify the regulating key 
molecules that define stem cell fate and behavior. 
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Methods 
Plasmid construction 
The firefly luciferase gene was derived by PCR from pGL3 basic vector (Promega) 
with a forward and reverse primer carrying EcoRI restriction site and inserted in 
pCAG-MS vector in EcoRI site. The 3’UTRs of Sirt1 (from nucleotide 2802 to 
4341), Jarid1b (from nucleotide 4804 to 6311) and Smarca5 (from nucleotide 3519 
to 3742) genes were obtained from ESCs by PCR with a sense and antisense 
primer carrying a KpnI restriction site. The 3’UTR and inverted 3’UTR of these 
three genes were cloned downstream to firefly luciferase gene in KpnI site in 
pCBA-GFP vector by replacing GFP (Parisi, Passaro et al. 2008). Sequences of 
oligonucleotides used for cloning are provided in Appendix 2.  
Cell culture, transfection and luciferase assay 
E14Tg2a (BayGenomics) mouse ESCs were maintained on feeder-free, gelatine 
coated plates in the following medium: GMEM (Sigma) supplemented with 2mM 
glutamine (Invitrogen), 100U/ml penicillin/streptomycin (Invitrogen), 1mM sodium 
pyruvate (Invitrogen), 1x non essential amino acids (Invitrogen), 0.1 mM !-
mercaptoethanol (Sigma), 10% FBS (Hyclone), and 103 U/ml leukemia inhibitory 
factor (LIF) (Millipore, Billerica, MA, USA). HEK293 cells were cultured in DMEM 
(Invitrogen) supplemented with 2mM glutamine (Invitrogen), 100U/ml 
penicillin/streptomycin (Invitrogen) and 10% FBS (Invitrogen). Both HEK293 cells 
and ESCs were plated at 6x104 cells/cm2 16 hours before transfection. 
Transfection of plasmids, shRNAs (Open Biosystems), pre-microRNAs (Ambion) 
and anti-microRNAs (Ambion) in ESCs were performed using Lipofectamine 2000 
following manifacturer’s instructions. To generate the stable cell lines, E14Tg2a 
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cells were transfected with luciferase expression plasmids (see above) and 
recombinant clones were selected with G418 (Invitrogen) or with shRNAs and 
silenced clones were selected with puromycin.  
For luciferase assay HEK293 cells were co-transfected with 500ng of pCAG-MS 
reporter vector carrying 3’UTR or inverted 3’UTR, 10ng pRL-TK vector (Promega) 
and 100nM of pre-microRNAs or scrambled oligonucleotides (both from Ambion) 
by using Lipofectamine 2000 (Invitrogen). Firefly and renilla luciferase activities 
were measured 48h after transfection. For E14 ESCs stably transfected with 
reporter vector or inverted reporter vector we performed luciferase activities at day 
4 of differentiation. Firefly and renilla luciferase activities were measured with the 
dual-luciferase reporter system (Promega) by Sirius Luminometer (Berthold 
Detection Sistems). The data generated were expressed as relative to scrambled 
oligonucleotide-transfected cells, after normalization to Renilla luciferase reading. 
All transfection experiments were repeated in triplicate. 
ESC differentiation 
ESCs were trypsinized into a single cells suspension, collected by centrifugation 
and resuspended in the following medium: Knockout Dulbecco’s minimal essential 
medium supplemented with 10% Knockout Serum Replacement (both from 
Invitrogen), 0.1 mM !-mercaptoethanol (Sigma), 2 mM glutamine (Invitrogen), 100 
U/mL penicillin/streptomycin (Invitrogen). To induce efficient neural differentiation 
the cells were plated at low density (3x103 cells/cm2) on gelatin-coated dishes and 
differentiation medium was changed on alternated days. 
RNA isolation and TaqMan analysis 
For TaqMan analysis total RNA was isolated from undifferentiated and two and 
four days differentiated ESCs with mirVana microRNA Isolation kit (Ambion). From 
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each sample, 10 ng of total RNA were used to synthesize single-stranded cDNA 
with TaqMan MicroRNA Reverse transcription kit (Applied Biosystems) combined 
with the two Rodent Megaplex RT Primer Pool (Pool A and Pool B). Expression 
level of all microRNAs of Sanger miRBase version 10 database were measured by 
using TaqMan MicroRNA Arrays (Applied Biosystems) with 7900HT instrument 
and the Sequence Detection Systems (SDS) Software version 2.1 (Applied 
Biosystems). The microRNA profiling data were analysed performing a 
comparative analysis by using the comparative Ct method (2-"Ct, RQ Manager 1.2 
software, Applied Biosystems).  
For Northern Blot analysis total RNA was isolated by using the TRI Reagent 
(Sigma) according to the manufacturer’s instructions. For each sample 20 #g of 
total RNA were fractionated on 15% TBE-Urea gel (Criterion precast Gel, Bio-
Rad), stained with EtBr (Sigma) for loading control, then transfered to Hybond 
membrane (Amersham Pharmacia) and finally fixed by UV cross-linking in a 
Stratalinker (Stratagene) according to manufacturer’s instruction. The membrane 
was hybridizated with 10pmol of miRCURY LNA Detection Probe digoxigenin 
labeled (Exiqon) according to manufacturer’s instruction. The signal detection was 
obtained by an anti-digoxigenin-Alkaline Phosphatase antibody (Roche) and a 
chemiluminescent substrate (CDP-Star, Roche) according to manufacturer’s 
instruction. 
  
Preparation of cell lysate and Western blot analysis 
Undifferentiated and differentiated ESCs were lysed in a buffer containing 1mM 
EDTA, 50 mM Tris-HCl pH 7.5, 70 mM NaCl , 1% Triton, protease inhibitor cocktail 
(Sigma) and protein extracts were analyzed by Western Blot. The following 
primary antibodies are used: rabbit anti-Smarca5 (hSNF2H H-300; Santa Cruz 
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Biotechnology), rabbit anti-KDM5B/Jarid1b (Abcam), rabbit anti-Sirt1 (Abcam), 
rabbit anti-p53 (Upstate), rabbit anti-acetylated-p53 in Lys379 (Cell Signaling), 
mouse anti-Gapdh (Santa Cruz). Antibody-protein complexes was detected by 
HRP-coniugated antibodies and ECL (both from Amersham Pharmacia). To 
analyze acetylated p53 levels by western blot analysis, ESCs were exposed to 
60J/M2 UV radiation and harvest after 16 hours. 
Chromatin Immuno Precipitation (ChIP) analysis 
Cells were cross-linked with 1% formaldehyde for 10 minutes at 37% and 
formaldehyde was then inactivated by the addition of 125 mM glycine. The 
chromatin was then sonicated to an average DNA-fragment length of 200-1000 bp. 
Soluble chromatin extracts were immunoprecipitated using anti-H3K4 antibody 
(upstate). Supernatant obtained without antibody was used as input control. The 
amount of Egr1 promoter in precipitated DNA was calculated by real-time PCR 
relative to the total input chromatin, and expressed as percent of total chromatin 
according to the following formula: 2Ct x 10, where Ct represents the cycle 
threshold and Ct = Ct(input) – Ct(immunoprecipitation) (Frank, Heim et al. 2002). 
Teratoma Formation 
Nude mice were injected subcutaneously with 2x106 ESC cells transfected with 
anti-miR mixture (left side) or anti-miR control (right side).  Four weeks after the 
injection, tumors were surgically dissected from the mice. Samples were fixed in 
4% paraformaldehyde, and embedded in paraffin. Sections were stained with 
heamatoxylin and eosin.   
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Real-Time PCR  
Total RNA was extracted by using TRI-Reagent (Sigma). The first-strand cDNA 
was synthesized according to the manufacturer’s instructions (M-MLV RT kit; 
Invitrogen). Real Time RT-PCR was carried out on ABI PRISM 7900HT Sequence 
Detection System (Applied Biosystems) using Power SYBR Green PCR Master 
mix (Applied Biosystems). The housekeeping GAPDH mRNA was used as an 
internal standard for normalization, using 2-"Ct method. Gene specific primers used 
for amplification are listed in Appendix 3.   
Alkaline phosphatase staining 
For alkaline phosphatase staining, ESCs were cultured at clonal density (100 
cells/10 cm2).  The cells were fixed in 10% cold Neutral Formalin Buffer (10% 
formalin, 110 mM Na2HPO4, 30mM NaH2PO4.H2O) for 15 minutes and then 
rinsed in distilled water for 15 minutes. The staining was obtained by incubation for 
45 minutes at room temperature with the following staining solution: 0.1M Tris-HCl, 
0.01% Naphthol AS MX-PO4 (Sigma), 0.4% N,N-Dimethylformamide (Sigma), 
0.06% Red Violet LB salt (Sigma). 
Bioinformatics analysis 
We took advantage from available data reporting gene expression profiles 
associated with differentiation induced by three chemical treatments (retinoic acid 
(RA), dimethyl sulfoxide (DMSO) and hexymethyl-bis-acetamide (HMBA), (Loh, 
Wu et al. 2006). In these arrays for each treatment, molecular profiles of treated 
cells were contrasted to that of untreated cells using two-channel microarrays 
across three time points. In total 18 microarrays data were available, in which the 
expression data was log transformed and median-center normalized. These 18 log 
expression data were treated as replicates, treatment and time factors were 
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ignored. So we used the absolute of average log expression ratio across the 18 
arrays and sorting them by ascending level of expression ratio after differentiation. 
We obtained a list of genes differentially expressed across differentiation and we 
selected only gene downregulated upon ESCs differentiation. The list of selected 
genes was compared with putative targets of our subset of microRNAs 
upregulated during ESC differentiation. Target prediction was performed with 
Targetscan version 5.1. 
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Appendix  
microRNA 
2 days 
(fold 
change) 
4 days 
(fold 
change) 
Ct ESCs Ct ESCs Ct 2d Ct 2d Ct 4d Ct 4d 
let-7a   40,000 40,000 40,000 40,000 40,000 40,000 
let-7a* 0,976 0,401 35,984 35,982 36,143 35,989 35,222 35,975 
let-7b 0,090 1,127 35,984 36,025 35,945 40,000 36,023 36,025 
let-7b*   40,000 40,000 40,000 40,000 40,000 40,000 
let-7c 1,521 2,144 34,985 33,977 33,970 34,972 32,956 32,946 
let-7c-1*   40,000 40,000 40,000 40,000 35,988 35,119 
let-7d*   40,000 40,000 40,000 40,000 40,000 40,000 
let-7e 0,791 4,900 32,971 33,004 32,977 34,006 30,972 29,959 
let-7f   40,000 40,000 40,000 40,000 40,000 40,000 
let-7f*   40,000 40,000 40,000 40,000 40,000 40,000 
let-7g 0,469 0,558 30,969 31,966 32,978 31,988 31,988 32,004 
let-7i 1,969 2,086 32,004 32,985 31,982 31,999 32,009 31,997 
let-7i*   40,000 40,000 40,000 40,000 40,000 40,000 
miR-1 5,544 5,750 35,922 35,994 34,968 33,976 32,961 33,988 
miR-100   40,000 40,000 31,002 30,996 25,994 25,994 
miR-101a 1,904 1,889 29,973 29,974 28,938 29,986 28,985 28,984 
miR-101b 1,154 0,986 27,938 27,914 27,897 27,970 26,943 26,860 
miR-103 3,503 4,547 28,999 28,979 27,994 27,987 26,989 26,994 
miR-105   40,000 40,000 40,000 40,000 40,000 40,000 
miR-106a 2,198 1,250 20,961 20,965 19,888 19,946 19,943 19,943 
miR-106b 1,895 2,236 25,967 25,957 25,966 25,975 24,971 24,976 
miR-106b* 1,060 0,992 27,868 27,933 27,866 27,909 26,947 26,797 
miR-107 3,135 4,198 34,002 32,973 32,937 32,000 32,036 30,958 
miR-10a* 0,950  35,980 34,991 35,801 35,982 40,000 40,000 
miR-10b   40,000 40,000 40,000 40,000 40,000 40,000 
miR-10b*   40,000 40,000 40,000 40,000 40,000 40,000 
miR-122   40,000 40,000 40,000 40,000 40,000 40,000 
miR-124 1,944 7,920 29,987 29,994 30,001 29,974 26,956 27,984 
miR-124*   40,000 40,000 30,748 31,402 29,878 29,483 
miR-125a-3p 2,304 1,208 33,978 33,966 32,961 32,978 32,974 32,978 
miR-125a-5p 1,288 1,932 27,979 27,959 28,984 28,975 26,978 26,984 
miR-125b*   40,000 40,000 33,966 35,961 32,114 32,863 
miR-125b-3p   40,000 40,000 40,000 40,000 34,962 33,965 
miR-125b-5p 0,815 11,232 29,986 29,967 30,976 30,975 26,981 25,963 
miR-126-3p 1,585 0,858 25,961 25,965 27,001 26,986 26,992 26,981 
miR-126-5p 1,732 0,855 29,978 29,961 29,973 29,972 29,977 29,970 
miR-127 2,879 0,975 24,950 24,947 24,975 24,992 24,937 24,954 
miR-127* 1,199 0,129 33,564 34,981 34,599 34,180 33,797 35,993 
miR-128a 5,037 2,383 33,971 32,982 31,972 31,962 31,967 31,974 
miR-129-3p 3,462 4,029 30,968 30,969 29,976 29,984 28,969 28,966 
miR-130a 2,599 2,576 25,958 25,967 25,971 25,972 24,966 24,960 
miR-130b 2,183 3,348 26,977 26,971 25,963 25,951 24,955 24,962 
miR-130b* 1,222 1,319 30,964 30,888 30,841 30,953 29,866 28,956 
miR-132 4,599 3,699 29,000 29,005 26,761 27,975 28,022 27,969 
miR-133a 3,875 7,243 31,983 31,997 29,968 29,989 28,980 28,986 
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miR-133a*   40,000 40,000 40,000 40,000 40,000 40,000 
miR-133b   40,000 40,000 40,000 40,000 30,937 32,031 
miR-134 1,714 0,741 24,961 25,986 24,978 24,994 25,990 25,969 
miR-135a 4,567 12,853 30,978 30,972 29,976 30,002 27,978 27,991 
miR-135a* 0,975 0,618 28,944 28,857 28,934 28,855 28,881 28,947 
miR-135b 1,403 0,809 24,977 24,972 24,959 24,987 24,973 24,973 
miR-136 1,588 0,647 26,983 26,954 26,958 27,996 27,967 27,985 
miR-137   40,000 40,000 35,010 33,976 29,961 30,978 
miR-138 2,348 2,488 29,959 30,985 29,970 29,973 28,958 28,963 
miR-138* 0,960 1,058 35,093 34,692 34,617 35,158 35,500 34,333 
miR-139-3p   40,000 40,000 40,000 40,000 40,000 40,000 
miR-139-5p 0,982 0,541 29,967 30,973 30,966 30,975 30,984 30,970 
miR-140 1,969 1,693 26,963 26,975 25,947 25,946 25,954 25,968 
miR-141 1,263 0,198 30,976 30,984 30,955 30,971 32,974 32,982 
miR-141* 0,516  32,471 31,043 31,974 33,994 40,000 40,000 
miR-142-3p 2,337 0,237 29,980 29,974 28,960 28,957 31,988 31,973 
miR-142-5p 3,521 0,423 34,966 34,982 33,973 32,964 34,976 35,918 
miR-143 3,203 5,355 30,978 30,963 30,986 29,966 28,983 28,969 
miR-145 1,942 3,214 28,958 29,982 28,969 28,970 27,979 27,984 
miR-145*   40,000 40,000 40,000 40,000 40,000 40,000 
miR-146a 2,087 1,731 29,983 29,983 28,968 28,970 28,982 28,972 
miR-146b 0,962 0,948 29,977 29,985 29,971 29,961 28,965 28,966 
miR-146b*   40,000 40,000 40,000 40,000 40,000 40,000 
miR-147   40,000 40,000 40,000 40,000 40,000 40,000 
miR-148a 3,113 1,808 28,938 28,949 27,949 28,971 27,937 28,983 
miR-148a*   40,000 40,000 40,000 40,000 40,000 40,000 
miR-148b 3,245 2,563 32,978 32,970 31,984 31,947 31,965 30,961 
miR-149 2,241 2,001 27,929 27,930 26,932 26,951 25,854 25,899 
miR-150 0,343 0,052 25,978 25,964 27,977 27,967 29,958 29,969 
miR-150*   40,000 40,000 40,000 40,000 40,000 40,000 
miR-151-3p 2,137 2,083 28,938 28,975 29,017 28,977 27,968 27,998 
miR-152 3,586 10,731 31,989 31,974 30,980 30,978 28,969 28,972 
miR-153   40,000 40,000 34,973 34,979 31,970 32,974 
miR-154* 1,102 0,235 30,920 30,771 30,585 30,967 32,305 31,869 
miR-155 0,892 0,641 28,946 28,947 29,946 29,961 28,939 28,948 
miR-15a 2,845 3,767 29,013 28,984 27,988 27,971 26,989 26,961 
miR-15a* 1,569 1,346 30,824 31,410 30,208 30,175 29,972 29,865 
miR-15b 2,310 2,150 27,972 27,982 26,993 26,963 26,977 26,960 
miR-15b* 1,242 0,845 28,731 28,795 28,814 28,974 28,811 28,848 
miR-16 1,078 1,172 22,994 22,947 22,941 22,964 22,984 22,980 
miR-16* 6,704 3,102 34,701 35,037 32,423 32,949 32,814 32,760 
miR-17 2,174 1,826 20,954 20,961 19,944 19,940 19,959 19,953 
miR-17* 0,917 0,576 31,168 31,435 31,913 31,815 31,338 30,857 
miR-181a 1,228 26,300 32,991 32,927 31,957 33,965 28,987 28,994 
miR-181a-1* 5,921 21,844 34,205 33,492 32,635 32,649 30,821 30,225 
miR-181c 0,837 1,435 31,932 31,982 32,946 31,964 31,975 31,992 
miR-182 1,840 0,359 23,954 24,989 23,947 23,959 25,993 25,971 
miR-183 1,583 0,349 28,981 28,996 27,989 27,997 29,977 29,965 
miR-183* 1,147 0,161 26,986 27,926 27,894 27,795 28,809 28,858 
miR-184 1,566 0,830 33,933 34,954 33,970 34,961 34,955 34,967 
miR-185 2,485 3,261 31,967 31,989 30,979 30,958 29,981 29,974 
 87 
miR-186 2,357 1,993 26,959 26,953 26,970 26,962 25,960 25,946 
miR-186* 2,952 1,616 31,465 30,938 29,734 29,840 29,843 29,849 
miR-187   40,000 40,000 40,000 40,000 32,987 32,011 
miR-188-3p   40,000 40,000 40,000 40,000 40,000 40,000 
miR-188-5p 1,867 1,238 30,945 30,933 30,956 30,948 30,945 29,928 
miR-18a 3,971 3,983 26,938 26,963 25,969 25,963 24,950 24,969 
miR-18a* 0,920 0,624 30,925 30,946 30,712 30,918 30,909 30,214 
miR-18b 4,455 1,546 31,966 31,978 29,969 31,005 30,957 30,990 
miR-190 2,282 1,687 32,972 33,970 32,968 32,979 32,967 32,980 
miR-190b 1,327 2,763 35,286 34,734 34,640 34,716 32,941 33,146 
miR-191 1,180 1,099 24,000 23,975 23,962 23,972 24,005 23,986 
miR-191* 1,511 0,810 34,814 36,272 35,405 34,906 35,378 35,867 
miR-192 2,183 1,918 30,966 30,962 30,984 30,973 30,973 29,968 
miR-193* 0,850 1,091 34,124 35,314 35,417 34,696 33,586 33,889 
miR-193b 0,951 1,123 29,998 29,970 29,958 29,964 28,951 28,970 
miR-194 2,006 1,863 32,987 33,004 31,976 32,006 31,996 32,012 
miR-195 1,996 0,770 27,973 27,968 27,975 27,962 27,967 27,978 
miR-196a* 0,961 0,251 35,099 34,954 34,984 34,975 35,919 34,307 
miR-197 3,161 3,863 31,967 32,056 30,960 30,965 30,967 31,991 
miR-199a-3p 1,431 2,186 31,984 31,970 30,974 32,004 30,983 30,979 
miR-199a-5p   40,000 40,000 40,000 40,000 40,000 40,000 
miR-199b*   40,000 40,000 40,000 40,000 40,000 40,000 
miR-19a 1,971 1,846 22,983 22,972 21,963 22,983 21,975 21,967 
miR-19b 2,918 2,300 18,977 19,985 18,991 18,966 17,945 18,070 
miR-200a 0,800 0,281 26,946 27,969 27,955 27,951 28,951 28,965 
miR-200a* 0,437 0,102 31,811 31,235 32,888 32,220 33,987 33,461 
miR-200b 0,872 0,267 25,990 25,978 26,990 26,989 27,978 27,973 
miR-200b* 0,269 0,085 32,445 32,917 34,215 33,223 36,042 33,408 
miR-200c 0,807 0,157 25,981 25,972 26,973 26,958 27,960 27,971 
miR-200c*   32,694 32,908 40,000 40,000 40,000 40,000 
miR-201   40,000 40,000 40,000 40,000 40,000 40,000 
miR-202-5p   40,000 40,000 40,000 40,000 40,000 40,000 
miR-203 1,271 0,650 29,975 29,974 29,957 29,968 29,962 30,976 
miR-204   40,000 40,000 31,991 32,963 32,000 31,993 
miR-205 0,547 0,496 30,974 31,986 31,019 31,973 32,011 32,013 
miR-206 0,775 10,224 36,992 35,942 36,782 36,890 33,694 33,956 
miR-207   40,000 40,000 40,000 40,000 40,000 40,000 
miR-208   40,000 40,000 40,000 40,000 40,000 40,000 
miR-208b   40,000 40,000 40,000 40,000 40,000 40,000 
miR-20a 1,636 1,509 21,971 21,955 21,973 21,963 20,955 20,956 
miR-20a* 1,593 1,469 28,983 29,030 28,954 28,945 27,818 27,964 
miR-20b 2,289 0,820 21,959 21,961 20,939 21,957 21,945 21,947 
miR-20b* 1,368 0,237 31,469 31,984 31,724 31,838 32,978 33,487 
miR-21 1,641 2,010 24,972 25,963 25,971 25,986 24,960 24,999 
miR-21* 2,256 0,991 35,207 34,977 33,981 34,469 33,954 34,527 
miR-210 0,217 0,467 26,991 26,987 28,977 28,989 26,959 26,976 
miR-211   31,979 31,977 40,000 40,000 40,000 40,000 
miR-214   40,000 40,000 40,000 40,000 40,000 40,000 
miR-214*   40,000 40,000 40,000 40,000 34,067 34,000 
miR-215   40,000 40,000 40,000 40,000 40,000 40,000 
miR-216a   40,000 40,000 32,962 34,003 31,995 33,023 
 88 
miR-216b   40,000 40,000 31,977 32,983 29,962 29,952 
miR-217   40,000 40,000 33,947 33,937 31,975 30,988 
miR-218 2,161 9,587 27,940 27,955 27,962 27,953 24,956 24,967 
miR-218-1* 0,255 1,681 35,956 35,041 35,817 35,300 34,727 35,639 
miR-218-2* 3,888 12,431 35,035 36,994 35,875 35,979 33,657 33,857 
miR-219   40,000 40,000 32,002 31,964 27,953 27,970 
miR-22 1,091 1,070 28,904 28,924 28,986 28,984 28,980 28,991 
miR-22* 2,182 1,025 32,741 32,887 31,883 31,822 31,933 32,280 
miR-220   40,000 40,000 40,000 40,000 40,000 40,000 
miR-221 1,346 1,785 28,957 28,973 28,989 28,969 29,001 28,990 
miR-222 0,772 0,747 26,943 26,944 27,946 27,956 26,938 26,941 
miR-223 4,051 6,474 35,974 36,027 33,997 35,983 34,989 33,967 
miR-224 1,439 1,224 31,973 31,987 31,983 31,972 30,966 30,960 
miR-23a   40,000 40,000 40,000 40,000 40,000 40,000 
miR-23b 1,756 0,740 31,969 32,980 31,991 31,965 31,968 31,999 
miR-24 0,870 0,984 22,960 22,961 23,975 24,988 23,985 23,988 
miR-24-2* 0,304 0,418 30,822 30,748 31,885 31,470 30,992 30,818 
miR-25 1,868 1,954 28,974 28,953 28,959 28,977 27,949 27,966 
miR-26a 1,456 1,718 25,965 25,969 25,961 25,965 24,963 24,949 
miR-26b 1,816 2,212 27,969 27,973 27,955 27,972 26,967 26,966 
miR-26b* 1,357 1,246 33,392 32,564 33,423 32,928 32,181 31,566 
miR-27a 0,705 1,071 28,952 28,955 29,957 29,963 28,977 28,969 
miR-27a* 0,355 0,180 30,872 30,944 31,833 31,894 32,332 31,951 
miR-27b 1,478 1,158 28,942 28,946 29,962 29,957 28,952 28,958 
miR-27b* 0,856 0,294 31,533 30,972 31,624 31,840 31,959 31,940 
miR-28 2,435 2,723 28,961 28,959 27,953 27,946 27,978 27,974 
miR-28* 0,821 0,831 29,110 29,107 29,487 28,884 28,789 28,957 
miR-290-3p 1,675 0,126 24,954 25,991 25,977 24,970 27,951 28,982 
miR-290-5p 0,471 0,053 23,835 23,930 24,806 24,847 27,918 27,900 
miR-291a-3p 0,911 0,168 21,969 21,962 22,974 22,961 23,944 24,981 
miR-291a-5p   27,679 27,783 40,000 40,000 40,000 40,000 
miR-291b-3p 0,663 0,499 35,899 34,998 34,514 33,982 35,989 35,328 
miR-291b-5p 2,036 0,109 28,958 28,979 28,958 28,959 31,987 31,995 
miR-292-3p 1,043 0,145 19,951 19,940 20,974 20,970 22,963 22,963 
miR-292-5p 0,622 0,048 28,923 28,952 28,776 28,756 31,245 30,827 
miR-293 1,534 0,259 19,970 19,971 19,952 19,960 21,971 21,970 
miR-293* 0,054 0,135 32,447 32,993 40,000 33,185 34,977 34,987 
miR-294 1,279 0,191 22,954 23,985 23,987 23,979 25,982 25,971 
miR-294* 0,701 0,056 26,969 26,971 26,955 26,943 28,844 28,886 
miR-295 0,873 0,149 19,987 19,984 20,981 20,985 21,969 21,984 
miR-296-3p 2,974 2,905 29,964 30,997 28,981 29,993 28,988 28,975 
miR-296-5p 1,641 1,002 27,995 27,941 28,016 27,975 28,000 27,964 
miR-297a* 1,309 0,587 27,842 28,117 27,860 27,969 28,052 28,920 
miR-297b-5p 1,863 0,943 30,973 30,975 29,972 29,946 29,966 30,966 
miR-297c 1,747 1,060 31,052 30,984 30,016 29,995 29,955 29,971 
miR-298 3,782 4,031 27,966 28,982 26,964 26,949 26,966 26,988 
miR-299* 0,899 0,342 30,887 30,137 30,931 30,930 31,024 30,836 
miR-29a 2,186 0,916 25,937 25,937 24,933 24,927 25,946 25,947 
miR-29a* 1,255 0,199 34,337 35,420 34,518 35,998 35,972 35,998 
miR-29b 1,989 1,034 32,958 34,993 33,999 32,973 33,973 32,963 
miR-29c 1,969 1,072 29,988 29,978 29,975 29,982 28,979 29,974 
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miR-300 1,621 0,258 30,647 31,203 30,614 30,916 31,261 31,600 
miR-300* 0,246 1,242 35,624 35,444 37,180 35,971 35,147 34,972 
miR-301a 1,857 3,677 25,978 25,972 25,980 25,985 23,979 23,943 
miR-301b 2,002 3,753 25,968 26,988 25,959 25,963 23,964 23,960 
miR-302a 7,537 3,926 24,956 25,962 22,959 22,958 22,953 22,957 
miR-302a* 4,501 1,148 29,920 29,187 26,965 27,901 28,944 28,081 
miR-302b 6,890 3,428 22,962 23,967 20,965 20,973 21,982 21,983 
miR-302b*   40,000 40,000 32,775 32,043 40,000 40,000 
miR-302c 6,734 4,133 28,018 27,982 26,990 26,997 25,965 26,994 
miR-302c* 6,734 1,804 33,185 33,195 30,987 30,933 31,957 32,000 
miR-302d 6,776 3,865 24,972 24,972 22,967 22,960 22,975 22,953 
miR-30a 1,495 1,806 27,928 28,970 28,962 28,961 27,952 27,956 
miR-30a* 1,069 1,609 27,867 27,917 27,965 27,762 25,926 25,915 
miR-30b 2,146 2,828 26,980 26,982 25,972 25,981 24,974 24,968 
miR-30b* 0,993 1,339 33,475 33,319 32,688 32,178 32,422 32,763 
miR-30c 2,235 2,703 25,977 25,971 24,954 24,949 23,954 23,945 
miR-30c-2*   40,000 40,000 40,000 40,000 40,000 40,000 
miR-30d 1,629 2,119 28,973 28,991 28,986 28,981 27,960 27,981 
miR-30e 1,827 1,875 26,922 27,953 26,921 26,925 26,952 26,950 
miR-30e* 1,117 1,331 27,856 27,956 27,798 27,881 26,847 26,873 
miR-31 1,338 1,477 26,965 26,970 26,969 26,967 25,974 25,960 
miR-31* 1,238 1,099 28,983 28,992 28,992 28,972 27,975 27,967 
miR-32 3,851 3,375 33,970 32,974 31,956 31,962 30,976 31,984 
miR-320 1,432 0,726 28,970 28,972 28,975 28,976 28,965 28,959 
miR-322 2,743 11,354 30,981 30,987 29,977 29,985 26,945 26,949 
miR-322* 1,407 8,223 33,990 33,994 32,985 33,045 29,992 29,996 
miR-323-3p 3,324 1,540 25,971 25,977 24,963 24,972 25,978 25,982 
miR-324-3p 1,452 2,684 29,982 30,039 30,015 30,003 28,976 28,990 
miR-324-5p 3,231 5,210 30,941 30,940 29,950 29,946 28,963 28,970 
miR-325   40,000 40,000 40,000 40,000 31,971 30,965 
miR-325*   40,000 40,000 40,000 40,000 33,000 32,987 
miR-326   40,000 40,000 40,000 40,000 30,427 29,934 
miR-328 10,429 13,193 32,959 31,968 29,977 30,973 28,977 28,969 
miR-329 1,986 1,912 32,969 32,955 32,971 31,946 31,971 31,966 
miR-33* 1,299 1,012 32,981 32,981 31,970 33,000 31,966 31,983 
miR-330 2,325 3,836 32,016 32,947 36,023 30,977 30,998 30,993 
miR-330*   40,000 40,000 40,000 40,000 40,000 40,000 
miR-331-3p 2,774 3,836 27,977 27,996 26,954 26,956 25,985 25,955 
miR-331-5p 7,329 4,346 32,972 33,955 31,985 32,993 31,995 31,970 
miR-335-3p 2,952 4,035 28,981 28,977 27,979 27,970 26,976 26,987 
miR-335-5p 5,634 15,634 29,953 29,980 27,953 28,967 25,958 25,985 
miR-337-3p 3,309 1,626 28,978 28,976 27,979 27,982 27,975 27,961 
miR-337-5p 3,347 1,442 28,959 29,979 27,959 28,987 28,979 28,977 
miR-339-3p 0,959 0,687 29,001 29,989 29,055 29,988 30,013 29,016 
miR-339-5p 3,437 3,269 30,952 31,986 29,982 30,982 29,978 29,987 
miR-340-3p 2,929 6,898 31,958 33,970 31,960 31,974 29,959 29,963 
miR-340-5p 3,751 7,799 29,967 30,999 29,988 28,970 27,967 27,965 
miR-342-3p 1,301 1,343 26,961 26,956 27,981 27,982 26,960 26,980 
miR-342-5p 2,752 8,228 35,989 36,040 33,011 34,005 32,033 31,976 
miR-343   40,000 40,000 40,000 40,000 40,000 40,000 
miR-344 3,340 4,471 30,987 30,987 29,996 29,988 29,979 29,999 
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miR-345   40,000 40,000 40,000 40,000 33,997 34,043 
miR-345-5p 2,988 4,386 32,040 31,971 31,969 30,982 30,991 29,967 
miR-346   40,000 40,000 40,000 40,000 40,000 40,000 
miR-34a 2,986 2,501 27,966 27,969 26,965 26,967 26,972 26,983 
miR-34b-3p 2,355 1,730 29,967 29,959 29,970 29,976 29,985 29,979 
miR-34c 3,498 7,576 32,985 32,986 30,981 32,970 30,972 30,979 
miR-34c* 1,255 0,792 28,969 28,954 28,975 28,969 28,953 28,973 
miR-350 3,537 5,012 32,980 32,990 31,979 31,970 30,981 30,968 
miR-351 4,143 10,921 30,971 31,980 30,974 30,987 29,989 29,989 
miR-361 1,268 1,533 31,977 31,968 31,973 31,989 30,985 30,979 
miR-362-3p 5,881 4,760 32,940 34,963 31,950 32,970 31,964 31,960 
miR-363 3,531 1,485 28,973 28,967 27,960 27,967 27,959 28,986 
miR-365 2,043 3,462 32,990 31,999 31,974 31,982 29,962 30,981 
miR-367 5,959 2,388 24,964 24,982 22,974 22,980 22,963 22,952 
miR-369-3p 3,034 1,874 33,973 34,980 32,970 33,987 32,960 32,950 
miR-369-5p 4,368 2,380 30,950 30,961 29,968 28,948 29,967 29,968 
miR-370 5,852 2,815 27,973 27,964 26,977 26,970 26,977 26,990 
miR-374 0,854 0,753 25,952 26,965 26,873 26,894 25,956 26,940 
miR-374*   40,000 40,000 40,000 40,000 40,000 40,000 
miR-376a 2,793 1,496 27,980 27,986 26,995 26,982 26,989 26,981 
miR-376a* 1,459 0,645 31,983 30,946 30,981 30,963 30,974 30,991 
miR-376b 2,516 0,597 26,986 26,999 26,999 25,966 27,988 28,020 
miR-376b* 1,211 0,451 27,953 27,959 27,964 27,978 27,953 27,939 
miR-376c 1,939 1,055 25,963 25,965 25,976 25,985 25,974 25,972 
miR-378 1,298 0,693 26,036 25,944 25,933 25,855 25,839 25,885 
miR-378* 0,901 0,367 33,974 33,955 33,969 33,963 34,973 32,955 
miR-379 2,415 1,207 25,931 25,943 25,958 25,957 25,950 25,947 
miR-380-3p 0,652 1,182 33,972 34,985 33,957 35,020 33,952 33,994 
miR-380-5p 4,703 3,020 29,984 29,989 27,965 27,971 27,966 27,969 
miR-381 3,776 2,086 34,987 33,981 32,982 33,975 33,985 32,963 
miR-382 2,964 1,628 27,989 28,011 25,936 25,998 25,975 26,977 
miR-382*   40,000 40,000 40,000 40,000 40,000 40,000 
miR-383   40,000 40,000 40,000 40,000 33,956 36,015 
miR-384-3p   40,000 40,000 40,000 40,000 31,980 31,988 
miR-384-5p 7,847 40,479 31,931 32,979 30,971 29,953 26,947 26,943 
miR-409-3p 2,002 0,655 23,955 24,973 23,961 23,951 24,957 24,965 
miR-409-5p 4,348 2,522 31,988 30,963 30,984 30,983 29,963 30,976 
miR-410 2,599 1,188 26,969 26,962 25,960 25,945 25,939 25,938 
miR-411 2,041 1,004 24,956 24,957 24,975 24,978 24,965 24,967 
miR-411* 1,162 0,575 30,973 31,048 31,989 31,976 31,982 31,978 
miR-425 1,385 0,906 27,946 27,984 28,035 27,973 27,972 27,946 
miR-425* 0,378 0,934 32,973 32,981 33,978 33,962 32,974 32,978 
miR-429 0,488 0,153 25,970 25,969 27,982 28,000 28,988 28,989 
miR-431 2,815 1,300 24,975 24,969 23,969 23,974 23,958 23,964 
miR-433 2,663 1,256 28,967 28,964 28,972 28,975 28,968 28,968 
miR-433*   40,000 40,000 40,000 40,000 40,000 40,000 
miR-434-3p 2,200 1,177 28,004 27,990 26,986 26,982 26,963 26,985 
miR-434-5p 3,529 1,324 30,991 30,983 28,987 29,989 29,982 29,984 
miR-448   40,000 40,000 40,000 40,000 40,000 40,000 
miR-449a 2,514 0,435 30,965 30,963 29,952 29,945 31,969 31,967 
miR-449b   40,000 40,000 40,000 40,000 40,000 40,000 
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miR-449c 1,067 0,410 34,337 32,870 33,284 33,634 33,807 35,989 
miR-450a-3p   40,000 40,000 40,000 40,000 40,000 40,000 
miR-450a-5p 3,374 3,463 32,953 34,003 32,967 32,981 31,976 31,973 
miR-450b-5p   40,000 40,000 40,000 40,000 40,000 40,000 
miR-451   40,000 40,000 40,000 40,000 40,000 40,000 
miR-452   40,000 40,000 40,000 40,000 40,000 40,000 
miR-453   40,000 40,000 40,000 40,000 40,000 40,000 
miR-455   40,000 40,000 40,000 40,000 40,000 40,000 
miR-455* 1,278 2,750 32,990 32,993 32,995 32,979 30,981 30,969 
miR-463*   40,000 40,000 40,000 40,000 40,000 40,000 
miR-464   40,000 40,000 40,000 40,000 40,000 40,000 
miR-465a-3p 2,055  34,964 33,974 33,986 34,986 40,000 40,000 
miR-465a-5p   40,000 40,000 40,000 40,000 40,000 40,000 
miR-465b-5p 1,071 0,127 32,001 31,976 31,972 31,972 33,989 33,988 
miR-466a-3p 0,975 0,210 28,695 28,843 28,593 28,878 29,838 29,886 
miR-466b-3-3p 1,167 0,250 28,971 28,870 28,967 28,889 29,669 29,827 
miR-466c-5p   40,000 40,000 40,000 40,000 40,000 40,000 
miR-466d-3p 1,148 0,394 23,986 23,836 23,901 23,975 23,900 23,863 
miR-466d-5p   40,000 40,000 40,000 40,000 40,000 40,000 
miR-466h   40,000 40,000 40,000 40,000 40,000 40,000 
miR-467a 2,887 1,655 24,979 24,963 23,967 23,968 23,968 23,982 
miR-467a* 1,043 0,423 27,977 27,957 27,970 27,971 28,985 27,963 
miR-467b 2,034 0,986 27,987 27,986 26,955 26,966 27,979 27,992 
miR-467b* 0,700 0,306 31,001 30,983 30,951 30,980 30,972 30,977 
miR-467c 2,245 1,013 26,986 26,990 27,011 25,971 26,980 26,974 
miR-467d 2,182 1,300 28,968 28,964 28,976 28,981 27,961 27,951 
miR-467e 2,271 1,122 28,998 29,970 28,977 28,982 28,986 28,988 
miR-467e*   32,022 31,957 40,000 40,000 40,000 40,000 
miR-468   40,000 40,000 40,000 40,000 40,000 40,000 
miR-469   40,000 40,000 40,000 40,000 40,000 40,000 
miR-470   40,000 40,000 40,000 40,000 40,000 40,000 
miR-483*   40,000 40,000 40,000 40,000 40,000 40,000 
miR-484 1,721 1,116 23,952 23,946 23,952 23,941 23,957 23,957 
miR-485* 0,645 0,082 26,972 26,965 27,990 27,987 29,981 29,969 
miR-486   40,000 40,000 40,000 40,000 29,968 30,003 
miR-487b 4,385 2,008 28,976 29,992 27,970 27,973 27,961 27,966 
miR-488*   40,000 40,000 40,000 40,000 40,000 40,000 
miR-489 0,916 0,183 29,969 29,961 30,983 30,975 31,956 31,946 
miR-490   40,000 40,000 40,000 40,000 40,000 40,000 
miR-491 1,373 1,619 30,936 31,980 30,984 30,982 30,959 30,978 
miR-493 13,656 6,504 33,984 35,005 32,989 32,967 32,959 32,992 
miR-494 2,352 1,327 25,986 26,984 25,981 25,989 25,981 25,964 
miR-495 2,783 0,883 26,959 26,942 26,967 26,958 27,967 27,977 
miR-496 4,886 1,784 33,983 33,975 32,974 32,981 32,971 33,987 
miR-497 2,595 0,655 29,990 29,987 28,976 28,979 29,978 29,983 
miR-499   40,000 40,000 40,000 40,000 40,000 40,000 
miR-500 2,071 3,775 31,977 31,963 31,990 30,972 30,976 30,972 
miR-501-5p 0,003 0,528 33,984 33,979 40,000 40,000 32,983 32,962 
miR-503 3,468 11,252 30,984 30,999 29,990 29,970 27,967 27,980 
miR-503* 2,395 4,484 32,968 33,984 31,966 32,984 30,986 30,976 
miR-504   40,000 40,000 40,000 40,000 40,000 40,000 
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miR-505   40,000 40,000 40,000 40,000 40,000 40,000 
miR-509-5p   40,000 40,000 40,000 40,000 40,000 40,000 
miR-511   40,000 40,000 40,000 40,000 40,000 40,000 
miR-532-3p 2,478 2,506 30,998 30,980 29,980 29,981 28,984 30,004 
miR-532-5p 2,438 2,477 26,976 27,982 26,967 26,971 25,960 25,961 
miR-539 2,588 1,085 26,930 26,944 26,953 26,956 26,948 26,941 
miR-540-3p 3,142 0,772 29,995 29,993 28,966 28,972 29,982 29,992 
miR-542-3p 2,901 2,183 34,980 33,976 33,986 33,982 32,967 33,983 
miR-542-5p 1,493 1,981 33,001 31,978 32,985 31,972 30,975 30,975 
miR-543 2,528 0,588 28,964 28,968 28,979 28,977 29,974 29,971 
miR-544 2,771 1,583 31,980 31,968 30,972 30,949 30,959 31,975 
miR-547   40,000 40,000 40,000 40,000 40,000 40,000 
miR-551b   40,000 40,000 40,000 40,000 40,000 40,000 
miR-574-3p 2,086 2,735 29,994 30,980 29,980 29,972 28,959 28,985 
miR-592 3,070 2,980 34,814 34,845 32,811 33,237 32,975 32,525 
miR-598   40,000 40,000 40,000 40,000 31,984 34,009 
miR-615-3p   40,000 40,000 40,000 40,000 40,000 40,000 
miR-615-5p   40,000 40,000 40,000 40,000 40,000 40,000 
miR-652 3,246 4,514 28,976 28,971 27,998 27,980 26,975 26,969 
miR-654-3p   40,000 40,000 40,000 40,000 40,000 40,000 
miR-654-5p   40,000 40,000 40,000 40,000 40,000 40,000 
miR-665 1,859 0,377 30,983 31,991 30,985 31,003 30,984 32,001 
miR-666-5p   40,000 40,000 40,000 40,000 40,000 40,000 
miR-667 2,704 1,453 27,961 27,967 27,979 27,973 27,993 27,990 
miR-668   40,000 40,000 40,000 40,000 40,000 40,000 
miR-669a 2,605 1,323 27,947 27,954 27,974 27,977 27,970 27,980 
miR-670 19,571 39,961 35,927 35,971 36,006 35,984 33,002 33,983 
miR-671-3p 28,445 14,740 35,971 35,997 32,988 32,998 32,988 32,999 
miR-672 0,649 0,133 26,967 26,952 27,953 27,951 28,961 28,954 
miR-673-3p 2,155 0,550 28,654 29,786 28,960 28,750 29,493 29,930 
miR-673-5p 1,244 0,300 30,715 30,633 30,928 30,779 31,331 31,381 
miR-674 1,957 1,579 30,982 30,997 29,984 29,970 29,976 29,961 
miR-674* 1,681 1,360 28,978 28,973 28,980 27,967 27,972 27,980 
miR-675-3p   40,000 40,000 40,000 40,000 40,000 40,000 
miR-675-5p   40,000 40,000 40,000 40,000 40,000 40,000 
miR-676 2,812 2,186 30,994 30,993 29,946 30,986 29,973 29,972 
miR-676* 1,291 1,660 35,983 34,988 34,979 33,985 33,988 33,970 
miR-678 1,167 0,605 31,732 31,683 31,710 31,974 31,365 31,955 
miR-679 3,566 0,945 33,051 32,991 31,965 31,980 31,940 31,975 
miR-680 2,509 1,204 29,976 29,981 28,951 28,970 28,985 30,027 
miR-681   40,000 40,000 40,000 40,000 40,000 40,000 
miR-682 2,315 1,707 32,007 31,996 30,979 30,934 30,950 31,985 
miR-683   40,000 40,000 40,000 40,000 40,000 40,000 
miR-684   40,000 40,000 40,000 40,000 35,005 35,971 
miR-685 1,913 2,625 28,985 28,991 29,001 29,004 27,976 27,961 
miR-686   40,000 40,000 40,000 40,000 40,000 40,000 
miR-687 1,986 1,125 26,072 25,947 24,896 25,986 24,995 25,961 
miR-688   40,000 40,000 40,000 40,000 40,000 40,000 
miR-690 0,967 0,897 23,982 23,955 23,942 23,967 23,967 23,932 
miR-691   40,000 40,000 40,000 40,000 40,000 40,000 
miR-692 1,045 0,281 28,832 28,695 29,049 28,789 29,403 29,580 
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miR-693-3p   40,000 40,000 40,000 40,000 40,000 40,000 
miR-693-5p   40,000 40,000 40,000 40,000 40,000 40,000 
miR-694 1,608 0,748 33,649 33,144 33,266 33,616 33,281 32,541 
miR-695   40,000 40,000 40,000 40,000 40,000 40,000 
miR-696 1,359 0,589 25,802 26,972 26,689 26,956 26,725 26,913 
miR-697 0,564 0,322 29,956 30,962 31,010 31,009 30,942 30,995 
miR-699 0,756 0,525 25,974 25,982 26,967 26,925 25,937 25,873 
miR-700 1,100 0,644 29,778 29,774 29,347 29,782 29,764 29,701 
miR-701 5,245 11,319 35,923 36,037 35,994 33,964 33,851 33,355 
miR-702 0,946 0,416 33,883 33,326 32,951 32,963 33,414 33,209 
miR-704 1,408 1,060 32,275 32,800 32,243 32,461 31,773 31,855 
miR-706 1,102 0,447 27,866 27,889 27,875 27,936 27,952 27,967 
miR-707   40,000 40,000 40,000 40,000 40,000 40,000 
miR-708 1,137 0,467 25,934 26,965 26,954 26,959 26,940 26,942 
miR-708*   34,985 33,978 40,000 40,000 40,000 40,000 
miR-709 1,283 0,633 22,914 22,945 22,963 22,953 22,925 22,939 
miR-710   40,000 40,000 40,000 40,000 40,000 40,000 
miR-711   40,000 40,000 40,000 40,000 40,000 40,000 
miR-712*   40,000 40,000 40,000 40,000 40,000 40,000 
miR-713   40,000 40,000 40,000 40,000 40,000 40,000 
miR-715   27,974 27,952 40,000 40,000 40,000 40,000 
miR-717   40,000 40,000 40,000 40,000 40,000 40,000 
miR-718   40,000 40,000 40,000 40,000 40,000 40,000 
miR-719   40,000 40,000 40,000 40,000 40,000 40,000 
miR-720 1,055 0,655 23,871 23,937 23,964 23,960 23,954 23,986 
miR-741 2,630 0,444 34,980 33,956 33,994 33,964 34,028 33,986 
miR-742   40,000 40,000 40,000 40,000 40,000 40,000 
miR-743a   40,000 40,000 31,007 31,045 31,013 29,901 
miR-743b-3p   35,004 35,012 40,000 40,000 40,000 40,000 
miR-743b-5p   40,000 40,000 40,000 40,000 40,000 40,000 
miR-744 2,859 3,695 29,970 29,954 28,948 28,953 27,953 27,957 
miR-744* 4,129 2,403 33,971 33,995 32,982 32,965 31,970 32,973 
miR-758   40,000 40,000 40,000 40,000 40,000 40,000 
miR-759   40,000 40,000 40,000 40,000 40,000 40,000 
miR-760 1,660 1,360 30,920 30,920 29,813 30,928 29,607 29,865 
miR-761   40,000 40,000 40,000 40,000 34,997 35,089 
miR-762   40,000 40,000 40,000 40,000 40,000 40,000 
miR-764-3p   40,000 40,000 40,000 40,000 40,000 40,000 
miR-764-5p 2,672 0,737 33,831 33,897 32,876 32,987 33,996 33,134 
miR-770-3p   40,000 40,000 40,000 40,000 40,000 40,000 
miR-7a 0,922 0,345 29,963 30,968 30,974 30,966 31,978 31,972 
miR-7a* 1,175 0,630 28,972 28,980 28,987 27,961 27,957 27,968 
miR-7b 0,640 0,210 32,955 32,988 33,967 33,975 34,983 35,002 
miR-801 0,751 0,465 29,823 29,884 30,850 30,859 31,791 31,222 
miR-802   40,000 40,000 40,000 40,000 40,000 40,000 
miR-804 0,939 0,866 33,046 32,961 33,121 33,934 32,483 32,312 
miR-805 0,710 0,505 25,929 25,821 26,831 26,687 25,867 25,648 
miR-871   40,000 40,000 40,000 40,000 40,000 40,000 
miR-872 2,566 3,170 29,965 29,953 28,942 28,945 27,947 27,948 
miR-872* 0,998 1,445 28,971 28,956 28,953 28,958 27,964 27,971 
miR-873   40,000 40,000 40,000 40,000 40,000 40,000 
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miR-874   40,000 40,000 40,000 40,000 40,000 40,000 
miR-875-3p   40,000 40,000 40,000 40,000 40,000 40,000 
miR-875-5p 0,652 0,274 33,230 33,461 32,843 34,834 33,739 35,445 
miR-876-3p   40,000 40,000 40,000 40,000 40,000 40,000 
miR-876-5p   40,000 40,000 40,000 40,000 40,000 40,000 
miR-877 1,108 0,722 31,235 30,960 31,859 30,957 30,849 30,734 
miR-877* 1,295 0,566 29,987 28,980 29,000 29,006 28,989 29,004 
miR-878-3p 0,524 0,446 31,670 31,429 31,883 31,794 31,774 31,971 
miR-878-5p   35,958 35,951 40,000 40,000 40,000 40,000 
miR-879   40,000 40,000 40,000 40,000 35,954 35,974 
miR-881 0,547  34,982 36,006 34,995 36,094 40,000 40,000 
miR-881*   34,010 34,978 40,000 40,000 40,000 40,000 
miR-883a-3p   40,000 40,000 40,000 40,000 40,000 40,000 
miR-883a-5p   40,000 40,000 40,000 40,000 40,000 40,000 
miR-9 2,659 15,103 27,978 28,022 26,939 26,989 23,971 23,958 
miR-9* 1,000 3,613 30,974 30,967 30,964 30,967 28,982 27,966 
miR-92a 1,821 0,804 23,939 23,950 23,951 23,947 24,962 24,963 
miR-92a* 1,821 0,230 29,982 29,989 28,969 28,966 30,989 30,982 
miR-93 1,915 2,419 24,967 24,964 23,946 23,944 22,942 22,950 
miR-93* 1,348 1,142 26,955 26,949 26,962 26,960 25,955 25,956 
miR-96 2,647 0,848 30,976 31,971 30,995 30,965 31,985 31,996 
miR-98   40,000 40,000 40,000 40,000 40,000 40,000 
miR-99a   40,000 40,000 30,958 31,991 25,004 25,977 
miR-99b 1,758 1,995 26,983 26,958 26,943 26,992 25,972 25,995 
miR-99b* 1,109 1,478 32,998 33,001 32,989 32,992 30,972 30,987 
 
Appendix 1. Full report of microRNA expression profile in undifferentiated 
ESCs and in two and four days differentiating ESC derivatives. 
 
 
Gene Forward primer (5’ to 3’) Reverse primer (5’ to 3’) 
Smarca5 GGGGTACCGCATTTTTGTCTTATAATCACTAACTG GGGGTACCCTACATACTATGTTTCTAGCTCAGTAAGC 
Jarid1b GGGGTACCTGTAATTCAGGACTCCAATAAAGAAG GGGGTACCGCTTATGGCTACAGACAGTGAGG 
Sirt1 GGGGTACCGATTCAGGAATTGCTCCACCAG   GGGGTACCGAAGATAATCCAGTCATTAAACGGTC 
Luc-EcoRI CCGGAATTCATGGAAGACGCCAAAAACATAAAG CCGGAATTCTTACACGGCGATCTTTCCGC 
 
Appendix 2. Primers used for cloning. 
 
 
Gene Forward primer (5’ to 3’) Reverse primer (5’ to 3’) 
Brachyury AGAAGACGAGGACGTGGCAG CATTACACACCACTGACGCACA 
Egr1 GGGAGAGGCAGGAAAGACATAA TCTGAGATCTTCCATCTGACCTAAGA 
Gapdh GTATGACTCCACTCACGGCAAA TTCCCATTCTCGGCCTTG 
Nanog TCAGAAGGGCTCAGCACCA GCGTTCACCAGATAGCCCTG 
Oct3/4 AACCTTCAGGAGATATGCAAATCG TTCTCAATGCTAGTTCGCTTTCTCT 
Rex1 GCAGTTTCTTCTTGGGATTTCAG CTAATGCCCACAGCGAT 
Sox1 CATCTCCAACTCTCAGGGCT ACTTGACCAGAGATCCGAGG 
Sox17 GATGCGGGATACGCCAGTG CCACCACCTCGCCTTTCAC 
 
Appendix 3. Primers used for Real-Time PCR. 
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Gene Forward primer (5’to3’) Reverse primer (5’to3’) 
Egr1 TTCACGTCACTCCGGGTCCTCC AGTTCTGCGCGCTGGGATCTCTC 
 
 
Appendix 4. Primers used for ChIP 
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